Drug-eluting stent (English Wikipedia)

Dehmer GJ, Smith KJ (December 2009). "Drug-Eluting Coronary Artery Stents". American Family Physician. 80 (11): 1245–1251. PMID 19961137. Archived from the original on 30 November 2023. Retrieved 15 March 2024.

acc.org

"IVUS in PCI Guidance". American College of Cardiology. Archived from the original on 24 November 2023. Retrieved 21 November 2023.
"Short Hospital Stays After Angioplasty Following Heart Attack Often Sufficient". American College of Cardiology. Archived from the original on 24 February 2024. Retrieved 21 November 2023.

acs.org

pubs.acs.org

Kirillova A, Yeazel TR, Asheghali D, Petersen SR, Dort S, Gall K, et al. (22 September 2021). "Fabrication of Biomedical Scaffolds Using Biodegradable Polymers". Chemical Reviews. 121 (18): 11238–11304. doi:10.1021/acs.chemrev.0c01200. PMID 33856196. Archived from the original on 13 March 2024. Retrieved 13 March 2024 – via CrossRef.

admet.com

Yalcin D (29 November 2019). "Mechanical Testing of Vascular Stents". ADMET. Archived from the original on 23 November 2023. Retrieved 23 November 2023.

ahajournals.org

Dawkins KD, Grube E, Guagliumi G, Banning AP, Zmudka K, Colombo A, et al. (22 November 2005). "Clinical Efficacy of Polymer-Based Paclitaxel-Eluting Stents in the Treatment of Complex, Long Coronary Artery Lesions From a Multicenter, Randomized Trial: Support for the Use of Drug-Eluting Stents in Contemporary Clinical Practice". Circulation. 112 (21): 3306–3313. doi:10.1161/CIRCULATIONAHA.105.552190. PMID 16286586. Archived from the original on 8 February 2024. Retrieved 8 February 2024 – via CrossRef.

bccresearch.com

"Drug-eluting Stent Market Size, share & Growth Research Report". www.bccresearch.com. Archived from the original on 24 November 2023. Retrieved 24 November 2023.

bhf.org.uk

"Coronary angioplasty and stents (PCI)". British Heart Foundation. Archived from the original on 21 November 2023. Retrieved 21 November 2023.

bmj.com

bmjopen.bmj.com

Yuan H, Wu Z, Lu T, Wei T, Zeng Y, Liu Y, et al. (2022). "Comparison of biodegradable and durable polymer drug-eluting stents in acute coronary syndrome: A meta-analysis". BMJ Open. 12 (6): e058075. doi:10.1136/bmjopen-2021-058075. PMC 9185674. PMID 35676012. Archived from the original on 8 August 2022. Retrieved 11 March 2024.

books.google.com

Katib N, Varcoe RL (2023). "Intervention for chronic lower limb ischemia". In Loftus I, Hinchliffe RJ (eds.). Vascular and Endovascular Surgery (7th ed.). Elsevier Health Sciences. pp. 39–57. ISBN 978-0-7020-8463-8. Archived from the original on 16 March 2024. Retrieved 4 March 2024.
Ellis SG, Holme DR (2006). Strategic Approaches in Coronary Intervention. Lippincott Williams & Wilkins. ISBN 978-0-7817-4294-8. Archived from the original on 20 October 2023. Retrieved 13 May 2015.

bostonscientific.com

"Promus PREMIER™ Drug-Eluting Coronary Stent System". www.bostonscientific.com. Archived from the original on 23 November 2023. Retrieved 23 November 2023.
"Clinical Trial Results - Eluvia Drug-Eluting Stent". www.bostonscientific.com. Archived from the original on 8 February 2024. Retrieved 8 February 2024.

britannica.com

"Atherosclerosis | Description, Pathophysiology, Risk Factors, & Treatment | Britannica". 13 March 2024. Archived from the original on 13 February 2024. Retrieved 15 March 2024.

cardiobrief.org

Husten L (6 April 2017). "Abbott Pulls Troubled Absorb Stent From European Market". CardioBrief. Archived from the original on 21 January 2021. Retrieved 2 November 2017.

cdc.gov

"Coronary Artery Disease". U.S. Centers for Disease Control and Prevention (CDC). 19 July 2021. Archived from the original on 2 March 2015. Retrieved 24 November 2023.
"How Cardiac Rehabilitation Can Help Heal Your Heart". U.S. Centers for Disease Control and Prevention. 12 September 2022. Archived from the original on 27 November 2023. Retrieved 21 November 2023.

clinicalcorrelations.org

Vani A (6 November 2013). "To Stent or Not to Stent?". Clinical Correlations. New York University (NYU) Department of Medicine. Archived from the original on 24 November 2023. Retrieved 24 November 2023.

clinicaltrials.gov

"Sirolimus-Eluting Stents for Chronic Total Coronary Occlusions - Full Text View - ClinicalTrials.gov". clinicaltrials.gov. 5 March 2007. Archived from the original on 13 April 2021. Retrieved 8 February 2024.
"Sirolimus-eluting Stents With Biodegradable Polymer Versus an Everolimus-eluting Stents - Full Text View - ClinicalTrials.gov". clinicaltrials.gov. 16 October 2018. Archived from the original on 15 May 2021. Retrieved 8 February 2024.
"Clinical Trial on the Efficacy and Safety of Sirolimus-Eluting Stent (MiStent® System) - Full Text View - ClinicalTrials.gov". clinicaltrials.gov. 3 September 2020. Archived from the original on 7 April 2021. Retrieved 8 February 2024.
"A Randomized, Double-blind Study to Assess Paclitaxel-eluting Stents in Treatment of Longer Lesions - Full Text View - ClinicalTrials.gov". clinicaltrials.gov. Archived from the original on 6 April 2021. Retrieved 8 February 2024.

columbiadoctors.org

"Drug-Eluting Stents Information". Archived from the original on 10 March 2024. Retrieved 10 March 2024.

dicardiology.com

"Abbott Restarts Bioresorbable Stent Clinical Trials with New Esprit Below-the-knee Scaffold". 3 September 2020. Archived from the original on 1 October 2023. Retrieved 11 March 2024.

doi.org

Stone G (2006). "Drug-eluting Stents - Current and Future Perspectives". Interventional Cardiology. 1 (1): 28–29. doi:10.15420/icr.2006.1.1.28. Archived from the original on 20 November 2023. Retrieved 20 November 2023.
Velagapudi C, Madassery S (November 2022). "Drug-eluting stents". Semin Intervent Radiol. 39 (4): 400–405. doi:10.1055/s-0042-1758078. PMC 9671677. PMID 36406018.
Iqbal J, Gunn J, Serruys PW (2013). "Coronary stents: historical development, current status and future directions". British Medical Bulletin. 106: 193–211. doi:10.1093/bmb/ldt009. PMID 23532779. S2CID 14423973.
Bin QS, Wen LS, Bo X, Jue C, Bo LH, Jin YY, et al. (September 2009). "Clinical outcomes for single stent and multiple stents in contemporary practice". Clin Cardiol. 32 (9): E33–9. doi:10.1002/clc.20516. PMC 6653171. PMID 19645042.
Tsagalou E, Chieffo A, Iakovou I, Ge L, Sangiorgi GM, Corvaja N, et al. (May 2005). "Multiple overlapping drug-eluting stents to treat diffuse disease of the left anterior descending coronary artery". J Am Coll Cardiol. 45 (10): 1570–3. doi:10.1016/j.jacc.2005.01.049. PMID 15893168.
Niu Y, Bai N, Ma Y, Zhong P, Shang Y, Wang Z (2022). "Efficacy of intravascular imaging-guided drug-eluting stent implantation: A systematic review and meta-analysis of randomized clinical trials". BMC Cardiovascular Disorders. 22 (1): 327. doi:10.1186/s12872-022-02772-w. PMC 9308935. PMID 35870904.
Wang Y, Mintz GS, Gu Z, Qi Y, Wang Y, Liu M, et al. (2018). "Meta-analysis and systematic review of intravascular ultrasound versus angiography-guided drug eluting stent implantation in left main coronary disease in 4592 patients". BMC Cardiovascular Disorders. 18 (1): 115. doi:10.1186/s12872-018-0843-z. PMC 6001000. PMID 29898668.
Li M, Tu H, Yan Y, Guo Z, Zhu H, Niu J, et al. (2023). "Meta-analysis of outcomes from drug-eluting stent implantation in femoropopliteal arteries". PLOS ONE. 18 (9): e0291466. Bibcode:2023PLoSO..1891466L. doi:10.1371/journal.pone.0291466. PMC 10513203. PMID 37733656.
Chen K, Xu L, Liu X (2024). "Different drugs in drug-eluting stents for peripheral artery disease: A systematic evaluation and Bayesian meta-analysis". Journal of Thrombosis and Thrombolysis. 57 (3): 520–530. doi:10.1007/s11239-023-02932-5. PMID 38281227. S2CID 267309550. Archived from the original on 11 March 2024. Retrieved 11 March 2024.
Hanawa T (1 June 2009). "Materials for metallic stents". Journal of Artificial Organs. 12 (2): 73–79. doi:10.1007/s10047-008-0456-x. PMID 19536623. S2CID 20660118.
Gonzalo N, Macaya C (2012). "Absorbable stent: focus on clinical applications and benefits". Vascular Health and Risk Management. 8: 125–132. doi:10.2147/VHRM.S22551. PMC 3295634. PMID 22399857.
Pradhan A, Vishwakarma P, Vankar S, Sethi R (2019). ""The Unpredictable ABSORB" - Very Late Stent Thrombosis of Bioresorbable Vascular Scaffold". Heart Views. 20 (2): 65–69. doi:10.4103/HEARTVIEWS.HEARTVIEWS_18_19. PMC 6686611. PMID 31462962.
Lee DH, de la Torre Hernandez JM (August 2018). "The Newest Generation of Drug-eluting Stents and Beyond". European Cardiology. 13 (1): 54–59. doi:10.15420/ecr.2018:8:2 (inactive 15 January 2025). PMC 6159420. PMID 30310472. Archived from the original on 22 October 2023. Retrieved 21 October 2023.{{cite journal}}: CS1 maint: DOI inactive as of January 2025 (link)
Bozsak F, Gonzalez-Rodriguez D, Sternberger Z, Belitz P, Bewley T, Chomaz J, et al. (2015). "Optimization of Drug Delivery by Drug-Eluting Stents". PLOS ONE. 10 (6): e0130182. Bibcode:2015PLoSO..1030182B. doi:10.1371/journal.pone.0130182. PMC 4470631. PMID 26083626.
Stevens JR, Zamani A, Osborne JI, Zamani R, Akrami M (2021). "Critical evaluation of stents in coronary angioplasty: A systematic review". BioMedical Engineering OnLine. 20 (1): 46. doi:10.1186/s12938-021-00883-7. PMC 8105986. PMID 33964954.
Ye Y, Xie H, Zeng Y, Zhao X, Tian Z, Zhang S (2013). "Efficacy and Safety of Biodegradable Polymer Biolimus-Eluting Stents versus Durable Polymer Drug-Eluting Stents: A Meta-Analysis". PLOS ONE. 8 (11): e78667. Bibcode:2013PLoSO...878667Y. doi:10.1371/journal.pone.0078667. PMC 3823917. PMID 24244335.
Yuan H, Wu Z, Lu T, Wei T, Zeng Y, Liu Y, et al. (2022). "Comparison of biodegradable and durable polymer drug-eluting stents in acute coronary syndrome: A meta-analysis". BMJ Open. 12 (6): e058075. doi:10.1136/bmjopen-2021-058075. PMC 9185674. PMID 35676012. Archived from the original on 8 August 2022. Retrieved 11 March 2024.
Gao K, Sun Y, Yang M, Han L, Chen L, Hu W, et al. (2017). "Efficacy and safety of polymer-free stent versus polymer-permanent drug-eluting stent in patients with acute coronary syndrome: A meta-analysis of randomized control trials". BMC Cardiovascular Disorders. 17 (1): 194. doi:10.1186/s12872-017-0603-5. PMC 5518142. PMID 28724348.
Saito Y, Kobayashi Y (2024). "Contemporary coronary drug-eluting and coated stents: An updated mini-review (2023)". Cardiovascular Intervention and Therapeutics. 39 (1): 15–17. doi:10.1007/s12928-023-00954-7. PMID 37656338. S2CID 261430959. Archived from the original on 24 November 2023. Retrieved 11 March 2024.
Watson T, Webster MWI (2017). "Long and short of optimal stent design". Open Heart. 4 (2): e000680. doi:10.1136/openhrt-2017-000680. PMC 5663262. PMID 29118997.
Liu L, Liu B, Ren J, Hui G, Qi C, Wang J (2018). "Comparison of drug-eluting balloon versus drug-eluting stent for treatment of coronary artery disease: A meta-analysis of randomized controlled trials". BMC Cardiovascular Disorders. 18 (1): 46. doi:10.1186/s12872-018-0771-y. PMC 5834842. PMID 29499651.
Abdelaziz A, Hafez A, Atta K, Elsayed H, Abdelaziz M, Elaraby A, et al. (2023). "Drug-coated balloons versus drug-eluting stents in patients with acute myocardial infarction undergoing percutaneous coronary intervention: An updated meta-analysis with trial sequential analysis". BMC Cardiovascular Disorders. 23 (1): 605. doi:10.1186/s12872-023-03633-w. PMC 10709955. PMID 38066453.
Coronary Artery Disease and the Evolution of Angioplasty Devices. SpringerBriefs in Materials. 2020. doi:10.1007/978-3-030-42443-5. ISBN 978-3-030-42442-8. S2CID 218682351. Archived from the original on 11 March 2024. Retrieved 11 March 2024.
McCormick C (2018). "Overview of cardiovascular stent designs". Functionalised Cardiovascular Stents. pp. 3–26. doi:10.1016/B978-0-08-100496-8.00001-9. ISBN 978-0-08-100496-8. Archived from the original on 11 March 2024. Retrieved 11 March 2024.
Murphy G, Naughton A, Durand R, Heron E, McCaughey C, Murphy R, et al. (2022). "50 Drug-eluting balloons and drug-eluting stents in the treatment of small coronary arteries: A systematic review and meta-analysis of long-term clinical outcomes". General posters. pp. A43 – A46. doi:10.1136/heartjnl-2022-ICS.50. Archived from the original on 11 March 2024. Retrieved 11 March 2024.
Jain KK (2011). "Coronary Angioplasty and Drug-Eluting Stents". Applications of Biotechnology in Cardiovascular Therapeutics. pp. 259–313. doi:10.1007/978-1-61779-240-3_9. ISBN 978-1-61779-239-7. Archived from the original on 11 March 2024. Retrieved 11 March 2024.
Oliva G, Espallargues M, Pons JM (2004). "Antiproliferative Drug-Eluting Stents: Systematic Review of the Benefits and Estimate of Economic Impact". Revista Española de Cardiología (English Edition). 57 (7): 617–628. doi:10.1016/S1885-5857(06)60285-5. PMID 15274846. Archived from the original on 11 March 2024. Retrieved 11 March 2024.
Hill R, Dündar Y, Bakhai A, Dickson R, Walley T (2004). "Drug-eluting stents: An early systematic review to inform policy*1, *2". European Heart Journal. 25 (11): 902–919. doi:10.1016/j.ehj.2004.03.023. PMID 15172462. Archived from the original on 11 March 2024. Retrieved 11 March 2024.
Kwon H, Park S (2014). "Local Delivery of Antiproliferative Agents via Stents". Polymers. 6 (3): 755–775. doi:10.3390/polym6030755.
Tran B (2021). "Assessment and management of peripheral arterial disease: What every cardiologist should know". Heart. 107 (22): 1835–1843. doi:10.1136/heartjnl-2019-316164. PMC 8562307. PMID 33985986. Archived from the original on 11 March 2024. Retrieved 11 March 2024.
Wei L, Leo HL, Chen Q, Li Z (2019). "Structural and Hemodynamic Analyses of Different Stent Structures in Curved and Stenotic Coronary Artery". Frontiers in Bioengineering and Biotechnology. 7: 366. doi:10.3389/fbioe.2019.00366. PMC 6908811. PMID 31867313.
Al Suwaidi J, Berger PB, Holmes Jr DR (2000). "Coronary Artery Stents". JAMA. 284 (14): 1828–1836. doi:10.1001/jama.284.14.1828. PMID 11025836. S2CID 31919688. Archived from the original on 17 June 2022. Retrieved 11 March 2024.
Mao H, Bao J (2018). "Peripheral Stent". In Jing Z, Mao H (eds.). Endovascular Surgery and Devices. Springer. pp. 43–57. doi:10.1007/978-981-10-8270-2_5. ISBN 978-981-10-8270-2. Retrieved 5 March 2024.
Yuan H, Wu Z, Lu T, Wei T, Zeng Y, Liu Y, et al. (2022). "Comparison of biodegradable and durable polymer drug-eluting stents in acute coronary syndrome: A meta-analysis". BMJ Open. 12 (6): e058075. doi:10.1136/bmjopen-2021-058075. PMC 9185674. PMID 35676012. Archived from the original on 11 March 2024. Retrieved 11 March 2024.
Zeng Y, Xu J, Deng Y, Li X, Chen W, Tang Y (2024). "Drug-eluting stents for coronary artery disease in the perspective of bibliometric analysis". Frontiers in Cardiovascular Medicine. 11. doi:10.3389/fcvm.2024.1288659. PMC 10910058. PMID 38440210.
Ernst A, Bulum J (2014). "New Generations of Drug-Eluting Stents – A Brief Review". EMJ Interventional Cardiology: 100–106. doi:10.33590/emjintcardiol/10312250.
Hong SJ, Hong MK (March 2022). "Drug-eluting stents for the treatment of coronary artery disease: A review of recent advances". Expert Opin Drug Deliv. 19 (3): 269–280. doi:10.1080/17425247.2022.2044784. PMID 35180832.
Serruys PW, Kutryk MJ, Ong AT (2 February 2006). "Coronary-Artery Stents". New England Journal of Medicine. 354 (5): 483–495. doi:10.1056/NEJMra051091. PMID 16452560. Archived from the original on 15 October 2022. Retrieved 15 March 2024.
Nordanstig J, Behrendt CA, et al. (January 2024). "Editor's Choice -- European Society for Vascular Surgery (ESVS) 2024 Clinical Practice Guidelines on the Management of Asymptomatic Lower Limb Peripheral Arterial Disease and Intermittent Claudication". Eur J Vasc Endovasc Surg. 67 (1): 9–96. doi:10.1016/j.ejvs.2023.08.067. hdl:1854/LU-01HNCQY1BMAPW8FMXQ74XZ4S4X. PMID 37949800. Retrieved 3 March 2024.
Chen K, Xu L, Liu X (2024). "Different drugs in drug-eluting stents for peripheral artery disease: A systematic evaluation and Bayesian meta-analysis". Journal of Thrombosis and Thrombolysis. 57 (3): 520–530. doi:10.1007/s11239-023-02932-5. PMID 38281227.
Abdullah K, Bou Dargham B, Steinbrecher M, Sun B, Huiqiang Z, Khalili H, et al. (2018). "Drug-Eluting Stents for Treatment of Peripheral Artery Disease". American Journal of Cardiovascular Drugs. 18 (3): 175–180. doi:10.1007/s40256-018-0265-4. PMID 29737505.
Bosiers M, Cagiannos C, Deloose K, Verbist J, Peeters P (2008). "Drug-eluting stents in the management of peripheral arterial disease". Vascular Health and Risk Management. 4 (3): 553–559. doi:10.2147/VHRM.S1712. PMC 2515416. PMID 18827906.
Jang BS, Kim E, Gwak MA, Park SA, Park WH (2023). "Fabrication and application of drug eluting stent for peripheral artery disease". Korean Journal of Chemical Engineering. 40 (2): 361–368. doi:10.1007/s11814-022-1286-x.
Pan C, Han Y, Lu J (2021). "Structural Design of Vascular Stents: A Review". Micromachines. 12 (7): 770. doi:10.3390/mi12070770. PMC 8305143. PMID 34210099.
Majewska P, Oledzka E, Sobczak M (January 2020). "Overview of the latest developments in the field of drug-eluting stent technology". Biomater Sci. 8 (2): 544–551. doi:10.1039/c9bm00468h. PMID 31701961. S2CID 207966529.
Yasmin F, Jawed K, Moeed A, Ali SH (January 2024). "Efficacy of Intravascular Imaging-Guided Drug-Eluting Stent Implantation: A Systematic Review and Meta-Analysis of Randomized Clinical Trials". Curr Probl Cardiol. 49 (1 Pt A): 102002. doi:10.1016/j.cpcardiol.2023.102002. PMID 37544623. S2CID 260681557.
Waksman R (December 2017). "A new generation of drug-eluting stents: Indications and outcomes of bioresorbable vascular scaffolds". Cleveland Clinic Journal of Medicine. 84 (12 Suppl 4): e20 – e24. doi:10.3949/ccjm.84.s4.05. PMID 29281608. S2CID 3663635.
Fischetti M (July 2006). "Vascular stents. Expanding use". Scientific American. 295 (1): 94–95. doi:10.1038/scientificamerican0706-94. PMID 16830686.
Cutlip DE (15 February 2017). "Dual Anti-platelet Therapy after Coronary Stenting: Rationale for Personalized Duration of Therapy". US Cardiol Rev. 11: 31–36. doi:10.15420/usc.2017:7:2. S2CID 108846490. Archived from the original on 20 November 2023. Retrieved 20 November 2023.
Koźlik M, Harpula J, Chuchra PJ, Nowak M, Wojakowski W, Gąsior P (February 2023). "Drug-Eluting Stents: Technical and Clinical Progress". Biomimetics. 8 (1): 72. doi:10.3390/biomimetics8010072. PMC 9944483. PMID 36810403.
Slavin L, Chhabra A, Tobis JM (2007). "Drug-eluting stents: preventing restenosis". Cardiology in Review. 15 (1): 1–12. doi:10.1097/01.crd.0000200844.16899.fc. PMID 17172878. S2CID 24548420.
George S, Butler R, Nolan J, Mamas MA (30 June 2016). "Percutaneous Coronary Intervention and Bleeding Complications". EMJ Interventional Cardiology. 4 (1): 100–109. doi:10.33590/emjintcardiol/10314557. ISSN 2053-423X. S2CID 256147538. Archived from the original on 19 November 2023. Retrieved 19 November 2023.
Habib A, Mori H, Yahagi K, Finn AV (3 February 2017). "Contemporary Drug-Eluting Stents and Vascular Response". EMJ Interventional Cardiology. 2 (1): 60–68. doi:10.33590/emj/10314324. ISSN 2053-423X. S2CID 13713278. Archived from the original on 5 November 2023. Retrieved 5 November 2023.
Patel S, Patel KB, Patel Z, Konat A, Patel A, Doshi JS, et al. (March 2023). "Evolving Coronary Stent Technologies - A Glimpse Into the Future". Cureus. 15 (3): e35651. doi:10.7759/cureus.35651. PMC 10065169. PMID 37009355.
Piccolo R, Bonaa KH, Efthimiou O, Varenne O, Baldo A, Urban P, et al. (June 2019). "Drug-eluting or bare-metal stents for percutaneous coronary intervention: a systematic review and individual patient data meta-analysis of randomised clinical trials". Lancet. 393 (10190): 2503–2510. doi:10.1016/S0140-6736(19)30474-X. PMID 31056295. S2CID 144207970.
Wu PN, Chen JH, Yang CP, Hsu JC (December 2022). "Advantages of DES over BMS in Preventing the Risk of Myocardial Infarction, Ischemic Stroke, and Mortality in Various Populations". Journal of Clinical Medicine. 12 (1): 24. doi:10.3390/jcm12010024. PMC 9820891. PMID 36614825.
Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM, Bischoff JM, et al. (January 2022). "2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines". Circulation. 145 (3): e18 – e114. doi:10.1161/CIR.0000000000001038. PMID 34882435. S2CID 245072028.
Arnold SV (2018). "Current Indications for Stenting: Symptoms or Survival ^CME". Methodist DeBakey Cardiovascular Journal. 14 (1): 7–13. doi:10.14797/mdcj-14-1-7. PMC 5880567. PMID 29623167.
Swap CJ, Nagurney JT (November 2005). "Value and limitations of chest pain history in the evaluation of patients with suspected acute coronary syndromes". JAMA. 294 (20): 2623–2629. doi:10.1001/jama.294.20.2623. PMID 16304077.
Iwamoto Y, Okamoto M, Hashimoto M, Fukuda Y, Iwamoto A, Iwasaki T, et al. (March 2012). "Better stent expansion by two-time inflation of stent balloon and its responsible mechanism". Journal of Cardiology. 59 (2): 160–166. doi:10.1016/j.jjcc.2011.12.003. PMID 22266460.
Spadaccio C, Benedetto U (July 2018). "Coronary artery bypass grafting (CABG) vs. percutaneous coronary intervention (PCI) in the treatment of multivessel coronary disease: quo vadis? -a review of the evidences on coronary artery disease". Annals of Cardiothoracic Surgery. 7 (4): 506–515. doi:10.21037/acs.2018.05.17. PMC 6082779. PMID 30094215.
Peels JO, Hautvast RW, de Swart JB, Huybregts MA, Umans VA, Arnold AE, et al. (February 2009). "Percutaneous coronary intervention without on-site surgical back-up; two-years registry of a large Dutch community hospital". International Journal of Cardiology. 132 (1): 59–65. doi:10.1016/j.ijcard.2007.10.037. PMID 18241941.
Kirtane AJ, Stone GW (September 2011). "How to minimize stent thrombosis". Circulation. 124 (11): 1283–1287. doi:10.1161/CIRCULATIONAHA.110.976829. PMID 21911796. S2CID 17063075.
Hassan S, Ali MN, Ghafoor B (April 2022). "Evolutionary perspective of drug eluting stents: from thick polymer to polymer free approach". Journal of Cardiothoracic Surgery. 17 (1): 65. doi:10.1186/s13019-022-01812-y. PMC 8981810. PMID 35379273.
Denktas AE, Grimes C (2018). "Percutaneous Coronary Intervention". In Levine GN (ed.). Cardiology Secrets. Elsevier. pp. 172–182. doi:10.1016/B978-0-323-47870-0.00019-2. ISBN 978-0-323-47870-0. 8 What is stent thrombosis? Stent thrombosis occurs when there is complete occlusion of the artery due to the formation of a thrombus in the stent. ... Stent thrombosis is a potentially catastrophic event and often presents as STEMI, requiring emergency revascularization. Stent thrombosis carries a mortality rate of 20% to 45%.
Anstrom KJ, Kong DF, Shaw LK, Califf RM, Kramer JM, Peterson ED, et al. (August 2008). "Long-term clinical outcomes following coronary stenting". Archives of Internal Medicine. 168 (15): 1647–1655. doi:10.1001/archinte.168.15.1647. PMID 18695078.
Serrano MC, Vavra AK, Jen M, Hogg ME, Murar J, Martinez J, et al. (May 2011). "Poly(diol-co-citrate)s as novel elastomeric perivascular wraps for the reduction of neointimal hyperplasia". Macromolecular Bioscience. 11 (5): 700–709. doi:10.1002/mabi.201000509. PMC 4068126. PMID 21341372.
Shlofmitz E, Ali ZA, Maehara A, Mintz GS, Shlofmitz R, Jeremias A (December 2020). "Intravascular Imaging-Guided Percutaneous Coronary Intervention: A Universal Approach for Optimization of Stent Implantation". Circulation: Cardiovascular Interventions. 13 (12): e008686. doi:10.1161/CIRCINTERVENTIONS.120.008686. PMID 33233934. S2CID 227169038.
Li M, Hou J, Gu X, Weng R, Zhong Z, Liu S (January 2022). "Incidence and risk factors of in-stent restenosis after percutaneous coronary intervention in patients from southern China". European Journal of Medical Research. 27 (1): 12. doi:10.1186/s40001-022-00640-z. PMC 8783476. PMID 35065663.
Lee MS, Shah AP, Aragon J, Jamali A, Dohad S, Kar S, et al. (December 2005). "Drug-eluting stenting is superior to bare metal stenting in saphenous vein grafts". Catheterization and Cardiovascular Interventions. 66 (4): 507–511. doi:10.1002/ccd.20498. PMID 16270361. S2CID 24315977.
Baldwin DE, Abbott JD, Trost JC, Vlachos HA, Selzer F, Glaser R, et al. (October 2010). "Comparison of drug-eluting and bare metal stents for saphenous vein graft lesions (from the National Heart, Lung, and Blood Institute Dynamic Registry)". The American Journal of Cardiology. 106 (7): 946–951. doi:10.1016/j.amjcard.2010.05.025. PMC 2945366. PMID 20854955.
Win HK, Caldera AE, Maresh K, Lopez J, Rihal CS, Parikh MA, et al. (May 2007). "Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents". JAMA. 297 (18): 2001–2009. doi:10.1001/jama.297.18.2001. PMID 17488965.
Beohar N, Davidson CJ, Kip KE, Goodreau L, Vlachos HA, Meyers SN, et al. (May 2007). "Outcomes and complications associated with off-label and untested use of drug-eluting stents". JAMA. 297 (18): 1992–2000. doi:10.1001/jama.297.18.1992. PMID 17488964.
Dixon SR, Grines CL, O'Neill WW (May 2010). "The year in interventional cardiology". Journal of the American College of Cardiology. 55 (20): 2272–86. doi:10.1016/j.jacc.2010.02.024. PMID 20466207.
Song JW, Soh S, Shim JK (January 2020). "Monitored Anesthesia Care for Cardiovascular Interventions". Korean Circulation Journal. 50 (1): 1–11. doi:10.4070/kcj.2019.0269. PMC 6923237. PMID 31642214.
Shuvy M, Ko DT (28 February 2014). "Bleeding after percutaneous coronary intervention: can we still ignore the obvious?". Open Heart. 1 (1): e000036. doi:10.1136/openhrt-2014-000036. PMC 4195920. PMID 25332793.
Thibert MJ, Fordyce CB, Cairns JA, Turgeon RD, Mackay M, Lee T, et al. (July 2021). "Access-Site vs Non-Access-Site Major Bleeding and In-Hospital Outcomes Among STEMI Patients Receiving Primary PCI". CJC Open. 3 (7): 864–871. doi:10.1016/j.cjco.2021.02.009. PMC 8347846. PMID 34401693.
Canfield J, Totary-Jain H (October 2018). "40 Years of Percutaneous Coronary Intervention: History and Future Directions". Journal of Personalized Medicine. 8 (4): 33. doi:10.3390/jpm8040033. PMC 6313463. PMID 30275411.
Dalal F, Dalal HM, Voukalis C, Gandhi MM (July 2017). "Management of patients after primary percutaneous coronary intervention for myocardial infarction". BMJ. 358: j3237. doi:10.1136/bmj.j3237. PMID 28729460. S2CID 46847680.
Dangas GD, Claessen BE, Caixeta A, Sanidas EA, Mintz GS, Mehran R (November 2010). "In-stent restenosis in the drug-eluting stent era". Journal of the American College of Cardiology. 56 (23): 1897–1907. doi:10.1016/j.jacc.2010.07.028. PMID 21109112.
Bønaa KH, Mannsverk J, Wiseth R, Aaberge L, Myreng Y, Nygård O, et al. (September 2016). "Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease". The New England Journal of Medicine. 375 (13): 1242–1252. doi:10.1056/NEJMoa1607991. PMID 27572953.
Shlofmitz E, Iantorno M, Waksman R (August 2019). "Restenosis of Drug-Eluting Stents: A New Classification System Based on Disease Mechanism to Guide Treatment and State-of-the-Art Review". Circulation: Cardiovascular Interventions. 12 (8): e007023. doi:10.1161/CIRCINTERVENTIONS.118.007023. PMID 31345066. S2CID 198912657.
Palmerini T, Benedetto U, Biondi-Zoccai G, Della Riva D, Bacchi-Reggiani L, Smits PC, et al. (June 2015). "Long-Term Safety of Drug-Eluting and Bare-Metal Stents: Evidence From a Comprehensive Network Meta-Analysis". Journal of the American College of Cardiology. 65 (23): 2496–2507. doi:10.1016/j.jacc.2015.04.017. hdl:11392/2415452. PMID 26065988.
Nikam N, Steinberg TB, Steinberg DH (2014). "Advances in stent technologies and their effect on clinical efficacy and safety". Medical Devices: Evidence and Research. 7: 165–178. doi:10.2147/MDER.S31869. PMC 4051714. PMID 24940085. S2CID 5022642.
Jaiswal V, Ang SP, Shrestha AB, Joshi A, Ishak A, Chia JE, et al. (June 2023). "Percutaneous coronary intervention versus coronary artery bypass grafting among patients with left ventricular systolic dysfunction: a systematic review and meta-analysis". Annals of Medicine and Surgery. 85 (6): 2849–2857. doi:10.1097/MS9.0000000000000634. PMC 10289746. PMID 37363575.
Grüntzig AR, Senning A, Siegenthaler WE (July 1979). "Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty". The New England Journal of Medicine. 301 (2): 61–68. doi:10.1056/NEJM197907123010201. PMID 449946.
Dotter CT, Judkins MP (November 1964). "Transluminal Treatment of Arteriosclerotic Obstruction. Description of a New Technic and a Preliminary Report of Its Application". Circulation. 30 (5): 654–670. doi:10.1161/01.CIR.30.5.654. PMID 14226164.
Serruys PW, Kutryk MJ, Ong AT (February 2006). "Coronary-artery stents". The New England Journal of Medicine. 354 (5): 483–495. doi:10.1056/NEJMra051091. PMID 16452560. S2CID 13647055.
Hwang CW, Wu D, Edelman ER (July 2001). "Physiological transport forces govern drug distribution for stent-based delivery". Circulation. 104 (5): 600–605. doi:10.1161/hc3101.092214. PMID 11479260.
Mauri L, Hsieh Wh, Massaro JM, Ho KK, D'Agostino R, Cutlip DE (8 March 2007). "Stent Thrombosis in Randomized Clinical Trials of Drug-Eluting Stents". New England Journal of Medicine. 356 (10): 1020–1029. doi:10.1056/NEJMoa067731. PMID 17296821. Archived from the original on 3 May 2023. Retrieved 8 February 2024 – via CrossRef.
Dawkins KD, Grube E, Guagliumi G, Banning AP, Zmudka K, Colombo A, et al. (22 November 2005). "Clinical Efficacy of Polymer-Based Paclitaxel-Eluting Stents in the Treatment of Complex, Long Coronary Artery Lesions From a Multicenter, Randomized Trial: Support for the Use of Drug-Eluting Stents in Contemporary Clinical Practice". Circulation. 112 (21): 3306–3313. doi:10.1161/CIRCULATIONAHA.105.552190. PMID 16286586. Archived from the original on 8 February 2024. Retrieved 8 February 2024 – via CrossRef.
Galløe AM, Thuesen L, Kelbæk H, Thayssen P, Rasmussen K, Hansen PR, et al. (30 January 2008). "Comparison of Paclitaxel- and Sirolimus-Eluting Stents in Everyday Clinical PracticeThe SORT OUT II Randomized Trial". JAMA. 299 (4): 409–416. doi:10.1001/jama.299.4.409. PMID 18230778. Archived from the original on 24 February 2024. Retrieved 8 February 2024 – via Silverchair.
Dai Y, Wang R, Chen F, Zhang Y, Liu Y, Huang H, et al. (12 November 2021). "Clinical outcomes in 2481 unselected real-world patients treated with a polymer-free sirolimus-eluting stent: 3 years results from the NANO multicenter Registry". BMC Cardiovascular Disorders. 21 (1): 537. doi:10.1186/s12872-021-02356-0. PMC 8588634. PMID 34772347.
Saito S, Bennett J, Nef HM, Webster M, Namiki A, Takahashi A, et al. (November 2023). "First randomised controlled trial comparing the sirolimus-eluting bioadaptor with the zotarolimus-eluting drug-eluting stent in patients with de novo coronary artery lesions: 12-month clinical and imaging data from the multi-centre, international, BIODAPTOR-RCT" (PDF). eClinicalMedicine. 65. doi:10.1016/j.eclinm.2023.102304. PMC 10725075. PMID 38106564. Archived (PDF) from the original on 8 February 2024. Retrieved 8 February 2024.
Uhrin P, Wang D, Mocan A, Waltenberger B, Breuss JM, Tewari D, et al. (November 2018). "Vascular smooth muscle cell proliferation as a therapeutic target. Part 2: Natural products inhibiting proliferation". Biotechnology Advances. 36 (6): 1608–1621. doi:10.1016/j.biotechadv.2018.04.002. PMID 29678389. S2CID 5027489.
Piccolo R, Bonaa KH, Efthimiou O, Varenne O, Baldo A, Urban P, et al. (June 2019). "Drug-eluting or bare-metal stents for percutaneous coronary intervention: a systematic review and individual patient data meta-analysis of randomised clinical trials - The Lancet" (PDF). The Lancet. 393 (10190): 2503–2510. doi:10.1016/S0140-6736(19)30474-X. PMID 31056295. Archived (PDF) from the original on 8 February 2024. Retrieved 8 February 2024.{{cite journal}}: CS1 maint: overridden setting (link)
Li M, Tu H, Yan Y, Guo Z, Zhu H, Niu J, et al. (21 September 2023). "Meta-analysis of outcomes from drug-eluting stent implantation in femoropopliteal arteries". PLOS ONE. 18 (9): e0291466. Bibcode:2023PLoSO..1891466L. doi:10.1371/journal.pone.0291466. PMC 10513203. PMID 37733656.
Brilakis ES, Wang TY, Rao SV, Banerjee S, Goldman S, Shunk K, et al. (2010). "Frequency and Predictors of Drug-Eluting Stent Use in Saphenous Vein Bypass Graft Percutaneous Coronary Interventions". JACC: Cardiovascular Interventions. 3 (10): 1068–1073. doi:10.1016/j.jcin.2010.07.009. PMID 20965466.
Krone RJ, Rao SV, Dai D, Anderson HV, Peterson ED, Brown MA, et al. (2010). "Acceptance, Panic, and Partial Recovery". JACC: Cardiovascular Interventions. 3 (9): 902–910. doi:10.1016/j.jcin.2010.06.014. PMID 20850088.
Aljihmani L, Alic L, Boudjemline Y, Hijazi ZM, Mansoor B, Serpedin E, et al. (2019). "Magnesium-Based Bioresorbable Stent Materials: Review of Reviews". Journal of Bio- and Tribo-Corrosion. 5 (1): 26. Bibcode:2019JBTC....5...26A. doi:10.1007/s40735-019-0216-x. S2CID 80811999. Archived from the original on 11 March 2024. Retrieved 11 March 2024.
Witte F, Eliezer A (2012). "Biodegradable Metals". Degradation of Implant Materials. Springer. pp. 93–109. doi:10.1007/978-1-4614-3942-4_5. ISBN 978-1-4614-3941-7. Archived from the original on 18 June 2018. Retrieved 11 March 2024.
Ormiston JA, Serruys PW (June 2009). "Bioabsorbable coronary stents". Circulation: Cardiovascular Interventions. 2 (3): 255–260. doi:10.1161/CIRCINTERVENTIONS.109.859173. PMID 20031723.
Charpentier E, Barna A, Guillevin L, Juliard JM (2015). "Fully bioresorbable drug-eluting coronary scaffolds: A review". Archives of Cardiovascular Diseases. 108 (6–7): 385–397. doi:10.1016/j.acvd.2015.03.009. PMID 26113479.
Ni L, Chen H, Luo Z, Yu Y (28 January 2020). "Bioresorbable vascular stents and drug-eluting stents in treatment of coronary heart disease: a meta-analysis". Journal of Cardiothoracic Surgery. 15 (1): 26. doi:10.1186/s13019-020-1041-5. PMC 6986072. PMID 31992360.
Omar WA, Kumbhani DJ (2019). "The Current Literature on Bioabsorbable Stents: A Review" (PDF). Current Atherosclerosis Reports. 21 (12): 54. doi:10.1007/s11883-019-0816-4. PMID 31768641. S2CID 208278983. Archived from the original on 11 March 2024. Retrieved 11 March 2024.
Yeazel TR, Becker ML (2020). "Advancing Toward 3D Printing of Bioresorbable Shape Memory Polymer Stents". Biomacromolecules. 21 (10): 3957–3965. doi:10.1021/acs.biomac.0c01082. PMID 32924443.
Kirillova A, Yeazel TR, Asheghali D, Petersen SR, Dort S, Gall K, et al. (22 September 2021). "Fabrication of Biomedical Scaffolds Using Biodegradable Polymers". Chemical Reviews. 121 (18): 11238–11304. doi:10.1021/acs.chemrev.0c01200. PMID 33856196. Archived from the original on 13 March 2024. Retrieved 13 March 2024 – via CrossRef.
Jackson-Smith E, Zioupos S, Banerjee P (2022). "Bioresorbable vascular scaffolds versus conventional drug-eluting stents across time: A meta-analysis of randomised controlled trials". Open Heart. 9 (2): e002107. doi:10.1136/openhrt-2022-002107. PMC 9615997. PMID 36288820.
Malmonge SM, Cliquet C (2023). "Fully Bioresorbable Vascular Stents". Current Trends in Biomedical Engineering. Springer. pp. 255–268. doi:10.1007/978-3-031-38743-2_14. ISBN 978-3-031-38742-5. Archived from the original on 11 March 2024. Retrieved 11 March 2024.
Kirtane AJ, Mauri L, Stoler R, Feldman R, Neumann FJ, Boutis L, et al. (22 September 2018). "TCT-841 Baseline characteristics and 3-month outcomes of the EVOLVE Short DAPT Trial: A prospective investigation of abbreviated antiplatelet therapy in high bleeding risk patients treated with a thin-strut bioabsorbable polymer-coated, everolimus-eluting coronary stent". Journal of the American College of Cardiology. 72 (13 Supplement): B335 – B336. doi:10.1016/j.jacc.2018.08.2086. ISSN 0735-1097.
Lansky A, Wijns W, Xu B, Kelbæk H, van Royen N, Zheng M, et al. (September 2018). "Targeted therapy with a localised abluminal groove, low-dose sirolimus-eluting, biodegradable polymer coronary stent (TARGET All Comers): a multicentre, open-label, randomised non-inferiority trial". Lancet. 392 (10153): 1117–1126. doi:10.1016/S0140-6736(18)31649-0. PMID 30190206. S2CID 52169067.
Saito Y, Kobayashi Y (September 2023). "Contemporary coronary drug-eluting and coated stents: an updated mini-review (2023)". Cardiovascular Intervention and Therapeutics. 39 (1): 15–17. doi:10.1007/s12928-023-00954-7. PMID 37656338. S2CID 261430959.
Nicolas J, Pivato CA, Chiarito M, Beerkens F, Cao D, Mehran R (May 2023). "Evolution of drug-eluting coronary stents: a back-and-forth journey from the bench to bedside". Cardiovascular Research. 119 (3): 631–646. doi:10.1093/cvr/cvac105. PMID 35788828.
Willich SN, Müller-Riemenschneider F, McBride D, Silber S, Kuck KH, Nienaber CA, et al. (February 2012). "Health economic evaluation of the use of drug-eluting stents: First results from the Drug-Eluting Stent Registry (DES.de)". Herz. 38 (1): 57–64. doi:10.1007/s00059-012-3581-5. PMID 22301731. S2CID 25967413.
Kuukasjärvi P, Räsänen P, Malmivaara A, Aronen P, Sintonen H (2007). "Economic evaluation of drug-eluting stents: a systematic literature review and model-based cost-utility analysis". International Journal of Technology Assessment in Health Care. 23 (4): 473–479. doi:10.1017/S0266462307070560. PMID 17937836. S2CID 31846667.
Stergiopoulos K, Brown DL (February 2012). "Initial coronary stent implantation with medical therapy vs medical therapy alone for stable coronary artery disease: meta-analysis of randomized controlled trials". Archives of Internal Medicine. 172 (4): 312–319. doi:10.1001/archinternmed.2011.1484. PMID 22371919.
Kureshi F, Jones PG, Buchanan DM, Abdallah MS, Spertus JA (September 2014). "Variation in patients' perceptions of elective percutaneous coronary intervention in stable coronary artery disease: cross sectional study". BMJ. 349: g5309. doi:10.1136/bmj.g5309. PMC 4157615. PMID 25200209.

ecrjournal.com

Lee DH, de la Torre Hernandez JM (August 2018). "The Newest Generation of Drug-eluting Stents and Beyond". European Cardiology. 13 (1): 54–59. doi:10.15420/ecr.2018:8:2 (inactive 15 January 2025). PMC 6159420. PMID 30310472. Archived from the original on 22 October 2023. Retrieved 21 October 2023.{{cite journal}}: CS1 maint: DOI inactive as of January 2025 (link)

ejves.com

Nordanstig J, Behrendt CA, et al. (January 2024). "Editor's Choice -- European Society for Vascular Surgery (ESVS) 2024 Clinical Practice Guidelines on the Management of Asymptomatic Lower Limb Peripheral Arterial Disease and Intermittent Claudication". Eur J Vasc Endovasc Surg. 67 (1): 9–96. doi:10.1016/j.ejvs.2023.08.067. hdl:1854/LU-01HNCQY1BMAPW8FMXQ74XZ4S4X. PMID 37949800. Retrieved 3 March 2024.

emjreviews.com

George S, Butler R, Nolan J, Mamas MA (30 June 2016). "Percutaneous Coronary Intervention and Bleeding Complications". EMJ Interventional Cardiology. 4 (1): 100–109. doi:10.33590/emjintcardiol/10314557. ISSN 2053-423X. S2CID 256147538. Archived from the original on 19 November 2023. Retrieved 19 November 2023.
Habib A, Mori H, Yahagi K, Finn AV (3 February 2017). "Contemporary Drug-Eluting Stents and Vascular Response". EMJ Interventional Cardiology. 2 (1): 60–68. doi:10.33590/emj/10314324. ISSN 2053-423X. S2CID 13713278. Archived from the original on 5 November 2023. Retrieved 5 November 2023.

europa.eu

ema.europa.eu

"Guideline on the development of medicinal substances contained in drug-eluting (medicinal substance-eluting) coronary stents" (PDF). London: European Medicines Agency. 22 March 2007. Archived (PDF) from the original on 8 February 2024. Retrieved 8 February 2024.

faegredrinker.com

"Annual Review of Medical Device Patent Litigation | Publications | Insights". Faegre Drinker Biddle & Reath LLP. Archived from the original on 24 November 2023. Retrieved 24 November 2023.

fda.gov

Center for Devices and RadiologicalHealth (15 August 2023). "Fluoroscopy". FDA. Archived from the original on 11 November 2023. Retrieved 21 November 2023.
"Overview of Medical Device Classification and Reclassification". FDA. 3 November 2018. Archived from the original on 19 November 2023. Retrieved 19 November 2023.
Commissioner Oo (3 November 2018). "Jurisdictional Update: Drug-Eluting Cardiovascular Stents". FDA. Archived from the original on 8 December 2023. Retrieved 8 February 2024 – via www.fda.gov.

fiercebiotech.com

Park A (3 February 2023). "Boston Scientific fined $42M in stent patent lawsuit". Fierce Biotech. Archived from the original on 24 November 2023. Retrieved 24 November 2023.

fiercemedicaldevices.com

Damian Garde for Fierce Medical Devices. 22 May 2013 Boston Scientific, Elixir make waves at EuroPCR 2013 Archived 16 January 2016 at the Wayback Machine
Hollmer M (30 January 2013). "In India, a call to halt financial incentives for stent use". Fierce Medical Devices. Archived from the original on 18 May 2015. Retrieved 13 May 2015.

handle.net

hdl.handle.net

Nordanstig J, Behrendt CA, et al. (January 2024). "Editor's Choice -- European Society for Vascular Surgery (ESVS) 2024 Clinical Practice Guidelines on the Management of Asymptomatic Lower Limb Peripheral Arterial Disease and Intermittent Claudication". Eur J Vasc Endovasc Surg. 67 (1): 9–96. doi:10.1016/j.ejvs.2023.08.067. hdl:1854/LU-01HNCQY1BMAPW8FMXQ74XZ4S4X. PMID 37949800. Retrieved 3 March 2024.
Palmerini T, Benedetto U, Biondi-Zoccai G, Della Riva D, Bacchi-Reggiani L, Smits PC, et al. (June 2015). "Long-Term Safety of Drug-Eluting and Bare-Metal Stents: Evidence From a Comprehensive Network Meta-Analysis". Journal of the American College of Cardiology. 65 (23): 2496–2507. doi:10.1016/j.jacc.2015.04.017. hdl:11392/2415452. PMID 26065988.

harvard.edu

ui.adsabs.harvard.edu

Li M, Tu H, Yan Y, Guo Z, Zhu H, Niu J, et al. (2023). "Meta-analysis of outcomes from drug-eluting stent implantation in femoropopliteal arteries". PLOS ONE. 18 (9): e0291466. Bibcode:2023PLoSO..1891466L. doi:10.1371/journal.pone.0291466. PMC 10513203. PMID 37733656.
Bozsak F, Gonzalez-Rodriguez D, Sternberger Z, Belitz P, Bewley T, Chomaz J, et al. (2015). "Optimization of Drug Delivery by Drug-Eluting Stents". PLOS ONE. 10 (6): e0130182. Bibcode:2015PLoSO..1030182B. doi:10.1371/journal.pone.0130182. PMC 4470631. PMID 26083626.
Ye Y, Xie H, Zeng Y, Zhao X, Tian Z, Zhang S (2013). "Efficacy and Safety of Biodegradable Polymer Biolimus-Eluting Stents versus Durable Polymer Drug-Eluting Stents: A Meta-Analysis". PLOS ONE. 8 (11): e78667. Bibcode:2013PLoSO...878667Y. doi:10.1371/journal.pone.0078667. PMC 3823917. PMID 24244335.
Li M, Tu H, Yan Y, Guo Z, Zhu H, Niu J, et al. (21 September 2023). "Meta-analysis of outcomes from drug-eluting stent implantation in femoropopliteal arteries". PLOS ONE. 18 (9): e0291466. Bibcode:2023PLoSO..1891466L. doi:10.1371/journal.pone.0291466. PMC 10513203. PMID 37733656.
Aljihmani L, Alic L, Boudjemline Y, Hijazi ZM, Mansoor B, Serpedin E, et al. (2019). "Magnesium-Based Bioresorbable Stent Materials: Review of Reviews". Journal of Bio- and Tribo-Corrosion. 5 (1): 26. Bibcode:2019JBTC....5...26A. doi:10.1007/s40735-019-0216-x. S2CID 80811999. Archived from the original on 11 March 2024. Retrieved 11 March 2024.

heartandstroke.ca

"Percutaneous coronary intervention". Heart and Stroke Foundation of Canada. Archived from the original on 23 November 2023. Retrieved 23 November 2023.

hellenicjcardiol.org

Gogas BD, Farooq V, Onuma Y, Serruys PW (2012). "The ABSORB bioresorbable vascular scaffold: an evolution or revolution in interventional cardiology?" (PDF). Hellenic Journal of Cardiology. 53 (4): 301–309. PMID 22796817. Archived (PDF) from the original on 9 August 2017. Retrieved 13 January 2016.

hey.nhs.uk

"Discharge advice after your coronary angiogram, angioplasty or stent insertion (PCI)". Hull University Teaching Hospitals NHS Trust. 9 April 2021. Archived from the original on 21 November 2023. Retrieved 21 November 2023.

icrjournal.com

Stone G (2006). "Drug-eluting Stents - Current and Future Perspectives". Interventional Cardiology. 1 (1): 28–29. doi:10.15420/icr.2006.1.1.28. Archived from the original on 20 November 2023. Retrieved 20 November 2023.

imrpress.com

McClean DR, Eigler NL (20 November 2002). "Stent Design: Implications for Restenosis". Reviews in Cardiovascular Medicine. 3 (S5): 16–22. Archived from the original on 8 December 2023. Retrieved 11 March 2024.

indiatimes.com

timesofindia.indiatimes.com

John DA (30 January 2013). "Unnecessary stent usage worries doctors across India". Times of India. Archived from the original on 26 June 2017. Retrieved 13 May 2015.
Nagarajan R (15 September 2014). "Profits from medical devices used to bribe doctors?". The Times of India. Archived from the original on 16 December 2016. Retrieved 13 May 2015.

insideradiology.com.au

Clark W, Burnes J (18 August 2016). "Angioplasty and Stent Insertion". InsideRadiology. Archived from the original on 29 November 2023. Retrieved 23 November 2023.
Goergen S (13 September 2016). "Iodine-containing contrast medium". InsideRadiology. Archived from the original on 7 July 2022. Retrieved 21 November 2023.

jamanetwork.com

Al Suwaidi J, Berger PB, Holmes Jr DR (2000). "Coronary Artery Stents". JAMA. 284 (14): 1828–1836. doi:10.1001/jama.284.14.1828. PMID 11025836. S2CID 31919688. Archived from the original on 17 June 2022. Retrieved 11 March 2024.

lownhospitalsindex.org

"Avoiding Overuse: Coronary Stents". Lown Institute Hospital Index. Archived from the original on 15 November 2023. Retrieved 21 November 2023.

lowninstitute.org

Toleos A (31 October 2023). "PRESS RELEASE: Unnecessary coronary stents cost Medicare as much as $800 million per year". Lown Institute. Archived from the original on 3 November 2023. Retrieved 3 November 2023.

massdevice.com

Densford F (31 July 2017). "Boston Scientific to end Renuvia bioresorbable coronary stent program – MassDevice". +MassDevice. Archived from the original on 7 November 2017. Retrieved 2 November 2017.
"Boston Scientific hit with $42M verdict in drug-eluting stents IP case". 2 February 2023. Archived from the original on 8 February 2024. Retrieved 8 February 2024.

medlineplus.gov

"Stent: MedlinePlus Medical Encyclopedia". Archived from the original on 5 July 2016. Retrieved 10 March 2024.

medscape.com

emedicine.medscape.com

Stouffer III GA, Yadav PK, Todd JW, Yousuf MA (27 November 2019). Peter K (ed.). "Percutaneous Coronary Intervention (PCI) Technique: Access, Procedure, Anatomic and Physiologic Assessment". emedicine.medscape.com. Archived from the original on 13 November 2023. Retrieved 21 November 2023.

medtronic.com

"Onyx Frontier DES - Coronary Stents". Medtronic. Archived from the original on 19 November 2023. Retrieved 23 November 2023.
Medtronic. "Onyx Frontier DES - Coronary Stents". www.medtronic.com. Archived from the original on 19 November 2023. Retrieved 19 November 2023.
"Onyx Frontier DES - Coronary Stents". Medtronic. Archived from the original on 19 November 2023. Retrieved 19 November 2023.

nejm.org

Serruys PW, Kutryk MJ, Ong AT (2 February 2006). "Coronary-Artery Stents". New England Journal of Medicine. 354 (5): 483–495. doi:10.1056/NEJMra051091. PMID 16452560. Archived from the original on 15 October 2022. Retrieved 15 March 2024.
Mauri L, Hsieh Wh, Massaro JM, Ho KK, D'Agostino R, Cutlip DE (8 March 2007). "Stent Thrombosis in Randomized Clinical Trials of Drug-Eluting Stents". New England Journal of Medicine. 356 (10): 1020–1029. doi:10.1056/NEJMoa067731. PMID 17296821. Archived from the original on 3 May 2023. Retrieved 8 February 2024 – via CrossRef.

nhs.uk

"Coronary angioplasty and stent insertion - Recovery". nhs.uk. 11 June 2018. Archived from the original on 24 December 2021. Retrieved 21 November 2023.

nih.gov

pubmed.ncbi.nlm.nih.gov

Senst B, Goyal A, Basit H, Borger J (2024). "Drug Eluting Stent Compounds". StatPearls. PMID 30726034. Archived from the original on 11 March 2024. Retrieved 10 March 2024.
Velagapudi C, Madassery S (November 2022). "Drug-eluting stents". Semin Intervent Radiol. 39 (4): 400–405. doi:10.1055/s-0042-1758078. PMC 9671677. PMID 36406018.
Iqbal J, Gunn J, Serruys PW (2013). "Coronary stents: historical development, current status and future directions". British Medical Bulletin. 106: 193–211. doi:10.1093/bmb/ldt009. PMID 23532779. S2CID 14423973.
Bin QS, Wen LS, Bo X, Jue C, Bo LH, Jin YY, et al. (September 2009). "Clinical outcomes for single stent and multiple stents in contemporary practice". Clin Cardiol. 32 (9): E33–9. doi:10.1002/clc.20516. PMC 6653171. PMID 19645042.
Tsagalou E, Chieffo A, Iakovou I, Ge L, Sangiorgi GM, Corvaja N, et al. (May 2005). "Multiple overlapping drug-eluting stents to treat diffuse disease of the left anterior descending coronary artery". J Am Coll Cardiol. 45 (10): 1570–3. doi:10.1016/j.jacc.2005.01.049. PMID 15893168.
Niu Y, Bai N, Ma Y, Zhong P, Shang Y, Wang Z (2022). "Efficacy of intravascular imaging-guided drug-eluting stent implantation: A systematic review and meta-analysis of randomized clinical trials". BMC Cardiovascular Disorders. 22 (1): 327. doi:10.1186/s12872-022-02772-w. PMC 9308935. PMID 35870904.
Wang Y, Mintz GS, Gu Z, Qi Y, Wang Y, Liu M, et al. (2018). "Meta-analysis and systematic review of intravascular ultrasound versus angiography-guided drug eluting stent implantation in left main coronary disease in 4592 patients". BMC Cardiovascular Disorders. 18 (1): 115. doi:10.1186/s12872-018-0843-z. PMC 6001000. PMID 29898668.
Li M, Tu H, Yan Y, Guo Z, Zhu H, Niu J, et al. (2023). "Meta-analysis of outcomes from drug-eluting stent implantation in femoropopliteal arteries". PLOS ONE. 18 (9): e0291466. Bibcode:2023PLoSO..1891466L. doi:10.1371/journal.pone.0291466. PMC 10513203. PMID 37733656.
Chen K, Xu L, Liu X (2024). "Different drugs in drug-eluting stents for peripheral artery disease: A systematic evaluation and Bayesian meta-analysis". Journal of Thrombosis and Thrombolysis. 57 (3): 520–530. doi:10.1007/s11239-023-02932-5. PMID 38281227. S2CID 267309550. Archived from the original on 11 March 2024. Retrieved 11 March 2024.
Hanawa T (1 June 2009). "Materials for metallic stents". Journal of Artificial Organs. 12 (2): 73–79. doi:10.1007/s10047-008-0456-x. PMID 19536623. S2CID 20660118.
Gonzalo N, Macaya C (2012). "Absorbable stent: focus on clinical applications and benefits". Vascular Health and Risk Management. 8: 125–132. doi:10.2147/VHRM.S22551. PMC 3295634. PMID 22399857.
Pradhan A, Vishwakarma P, Vankar S, Sethi R (2019). ""The Unpredictable ABSORB" - Very Late Stent Thrombosis of Bioresorbable Vascular Scaffold". Heart Views. 20 (2): 65–69. doi:10.4103/HEARTVIEWS.HEARTVIEWS_18_19. PMC 6686611. PMID 31462962.
Lee DH, de la Torre Hernandez JM (August 2018). "The Newest Generation of Drug-eluting Stents and Beyond". European Cardiology. 13 (1): 54–59. doi:10.15420/ecr.2018:8:2 (inactive 15 January 2025). PMC 6159420. PMID 30310472. Archived from the original on 22 October 2023. Retrieved 21 October 2023.{{cite journal}}: CS1 maint: DOI inactive as of January 2025 (link)
Bozsak F, Gonzalez-Rodriguez D, Sternberger Z, Belitz P, Bewley T, Chomaz J, et al. (2015). "Optimization of Drug Delivery by Drug-Eluting Stents". PLOS ONE. 10 (6): e0130182. Bibcode:2015PLoSO..1030182B. doi:10.1371/journal.pone.0130182. PMC 4470631. PMID 26083626.
Stevens JR, Zamani A, Osborne JI, Zamani R, Akrami M (2021). "Critical evaluation of stents in coronary angioplasty: A systematic review". BioMedical Engineering OnLine. 20 (1): 46. doi:10.1186/s12938-021-00883-7. PMC 8105986. PMID 33964954.
Ye Y, Xie H, Zeng Y, Zhao X, Tian Z, Zhang S (2013). "Efficacy and Safety of Biodegradable Polymer Biolimus-Eluting Stents versus Durable Polymer Drug-Eluting Stents: A Meta-Analysis". PLOS ONE. 8 (11): e78667. Bibcode:2013PLoSO...878667Y. doi:10.1371/journal.pone.0078667. PMC 3823917. PMID 24244335.
Yuan H, Wu Z, Lu T, Wei T, Zeng Y, Liu Y, et al. (2022). "Comparison of biodegradable and durable polymer drug-eluting stents in acute coronary syndrome: A meta-analysis". BMJ Open. 12 (6): e058075. doi:10.1136/bmjopen-2021-058075. PMC 9185674. PMID 35676012. Archived from the original on 8 August 2022. Retrieved 11 March 2024.
Gao K, Sun Y, Yang M, Han L, Chen L, Hu W, et al. (2017). "Efficacy and safety of polymer-free stent versus polymer-permanent drug-eluting stent in patients with acute coronary syndrome: A meta-analysis of randomized control trials". BMC Cardiovascular Disorders. 17 (1): 194. doi:10.1186/s12872-017-0603-5. PMC 5518142. PMID 28724348.
Saito Y, Kobayashi Y (2024). "Contemporary coronary drug-eluting and coated stents: An updated mini-review (2023)". Cardiovascular Intervention and Therapeutics. 39 (1): 15–17. doi:10.1007/s12928-023-00954-7. PMID 37656338. S2CID 261430959. Archived from the original on 24 November 2023. Retrieved 11 March 2024.
Watson T, Webster MWI (2017). "Long and short of optimal stent design". Open Heart. 4 (2): e000680. doi:10.1136/openhrt-2017-000680. PMC 5663262. PMID 29118997.
Liu L, Liu B, Ren J, Hui G, Qi C, Wang J (2018). "Comparison of drug-eluting balloon versus drug-eluting stent for treatment of coronary artery disease: A meta-analysis of randomized controlled trials". BMC Cardiovascular Disorders. 18 (1): 46. doi:10.1186/s12872-018-0771-y. PMC 5834842. PMID 29499651.
Abdelaziz A, Hafez A, Atta K, Elsayed H, Abdelaziz M, Elaraby A, et al. (2023). "Drug-coated balloons versus drug-eluting stents in patients with acute myocardial infarction undergoing percutaneous coronary intervention: An updated meta-analysis with trial sequential analysis". BMC Cardiovascular Disorders. 23 (1): 605. doi:10.1186/s12872-023-03633-w. PMC 10709955. PMID 38066453.
Oliva G, Espallargues M, Pons JM (2004). "Antiproliferative Drug-Eluting Stents: Systematic Review of the Benefits and Estimate of Economic Impact". Revista Española de Cardiología (English Edition). 57 (7): 617–628. doi:10.1016/S1885-5857(06)60285-5. PMID 15274846. Archived from the original on 11 March 2024. Retrieved 11 March 2024.
Hill R, Dündar Y, Bakhai A, Dickson R, Walley T (2004). "Drug-eluting stents: An early systematic review to inform policy*1, *2". European Heart Journal. 25 (11): 902–919. doi:10.1016/j.ehj.2004.03.023. PMID 15172462. Archived from the original on 11 March 2024. Retrieved 11 March 2024.
Tran B (2021). "Assessment and management of peripheral arterial disease: What every cardiologist should know". Heart. 107 (22): 1835–1843. doi:10.1136/heartjnl-2019-316164. PMC 8562307. PMID 33985986. Archived from the original on 11 March 2024. Retrieved 11 March 2024.
Wei L, Leo HL, Chen Q, Li Z (2019). "Structural and Hemodynamic Analyses of Different Stent Structures in Curved and Stenotic Coronary Artery". Frontiers in Bioengineering and Biotechnology. 7: 366. doi:10.3389/fbioe.2019.00366. PMC 6908811. PMID 31867313.
Al Suwaidi J, Berger PB, Holmes Jr DR (2000). "Coronary Artery Stents". JAMA. 284 (14): 1828–1836. doi:10.1001/jama.284.14.1828. PMID 11025836. S2CID 31919688. Archived from the original on 17 June 2022. Retrieved 11 March 2024.
Yuan H, Wu Z, Lu T, Wei T, Zeng Y, Liu Y, et al. (2022). "Comparison of biodegradable and durable polymer drug-eluting stents in acute coronary syndrome: A meta-analysis". BMJ Open. 12 (6): e058075. doi:10.1136/bmjopen-2021-058075. PMC 9185674. PMID 35676012. Archived from the original on 11 March 2024. Retrieved 11 March 2024.
Zeng Y, Xu J, Deng Y, Li X, Chen W, Tang Y (2024). "Drug-eluting stents for coronary artery disease in the perspective of bibliometric analysis". Frontiers in Cardiovascular Medicine. 11. doi:10.3389/fcvm.2024.1288659. PMC 10910058. PMID 38440210.
Hong SJ, Hong MK (March 2022). "Drug-eluting stents for the treatment of coronary artery disease: A review of recent advances". Expert Opin Drug Deliv. 19 (3): 269–280. doi:10.1080/17425247.2022.2044784. PMID 35180832.
Serruys PW, Kutryk MJ, Ong AT (2 February 2006). "Coronary-Artery Stents". New England Journal of Medicine. 354 (5): 483–495. doi:10.1056/NEJMra051091. PMID 16452560. Archived from the original on 15 October 2022. Retrieved 15 March 2024.
Nordanstig J, Behrendt CA, et al. (January 2024). "Editor's Choice -- European Society for Vascular Surgery (ESVS) 2024 Clinical Practice Guidelines on the Management of Asymptomatic Lower Limb Peripheral Arterial Disease and Intermittent Claudication". Eur J Vasc Endovasc Surg. 67 (1): 9–96. doi:10.1016/j.ejvs.2023.08.067. hdl:1854/LU-01HNCQY1BMAPW8FMXQ74XZ4S4X. PMID 37949800. Retrieved 3 March 2024.
Chen K, Xu L, Liu X (2024). "Different drugs in drug-eluting stents for peripheral artery disease: A systematic evaluation and Bayesian meta-analysis". Journal of Thrombosis and Thrombolysis. 57 (3): 520–530. doi:10.1007/s11239-023-02932-5. PMID 38281227.
Abdullah K, Bou Dargham B, Steinbrecher M, Sun B, Huiqiang Z, Khalili H, et al. (2018). "Drug-Eluting Stents for Treatment of Peripheral Artery Disease". American Journal of Cardiovascular Drugs. 18 (3): 175–180. doi:10.1007/s40256-018-0265-4. PMID 29737505.
Bosiers M, Cagiannos C, Deloose K, Verbist J, Peeters P (2008). "Drug-eluting stents in the management of peripheral arterial disease". Vascular Health and Risk Management. 4 (3): 553–559. doi:10.2147/VHRM.S1712. PMC 2515416. PMID 18827906.
Pan C, Han Y, Lu J (2021). "Structural Design of Vascular Stents: A Review". Micromachines. 12 (7): 770. doi:10.3390/mi12070770. PMC 8305143. PMID 34210099.
Majewska P, Oledzka E, Sobczak M (January 2020). "Overview of the latest developments in the field of drug-eluting stent technology". Biomater Sci. 8 (2): 544–551. doi:10.1039/c9bm00468h. PMID 31701961. S2CID 207966529.
Yasmin F, Jawed K, Moeed A, Ali SH (January 2024). "Efficacy of Intravascular Imaging-Guided Drug-Eluting Stent Implantation: A Systematic Review and Meta-Analysis of Randomized Clinical Trials". Curr Probl Cardiol. 49 (1 Pt A): 102002. doi:10.1016/j.cpcardiol.2023.102002. PMID 37544623. S2CID 260681557.
Waksman R (December 2017). "A new generation of drug-eluting stents: Indications and outcomes of bioresorbable vascular scaffolds". Cleveland Clinic Journal of Medicine. 84 (12 Suppl 4): e20 – e24. doi:10.3949/ccjm.84.s4.05. PMID 29281608. S2CID 3663635.
Fischetti M (July 2006). "Vascular stents. Expanding use". Scientific American. 295 (1): 94–95. doi:10.1038/scientificamerican0706-94. PMID 16830686.
Koźlik M, Harpula J, Chuchra PJ, Nowak M, Wojakowski W, Gąsior P (February 2023). "Drug-Eluting Stents: Technical and Clinical Progress". Biomimetics. 8 (1): 72. doi:10.3390/biomimetics8010072. PMC 9944483. PMID 36810403.
Slavin L, Chhabra A, Tobis JM (2007). "Drug-eluting stents: preventing restenosis". Cardiology in Review. 15 (1): 1–12. doi:10.1097/01.crd.0000200844.16899.fc. PMID 17172878. S2CID 24548420.
Dehmer GJ, Smith KJ (December 2009). "Drug-Eluting Coronary Artery Stents". American Family Physician. 80 (11): 1245–1251. PMID 19961137. Archived from the original on 30 November 2023. Retrieved 15 March 2024.
Ahmad M, Mehta P, Reddivari AK, Mungee S (2023). "Percutaneous Coronary Intervention". StatPearls. Treasure Island (FL): StatPearls Publishing. PMID 32310583. Archived from the original on 4 June 2023. Retrieved 21 November 2023.
Patel S, Patel KB, Patel Z, Konat A, Patel A, Doshi JS, et al. (March 2023). "Evolving Coronary Stent Technologies - A Glimpse Into the Future". Cureus. 15 (3): e35651. doi:10.7759/cureus.35651. PMC 10065169. PMID 37009355.
Piccolo R, Bonaa KH, Efthimiou O, Varenne O, Baldo A, Urban P, et al. (June 2019). "Drug-eluting or bare-metal stents for percutaneous coronary intervention: a systematic review and individual patient data meta-analysis of randomised clinical trials". Lancet. 393 (10190): 2503–2510. doi:10.1016/S0140-6736(19)30474-X. PMID 31056295. S2CID 144207970.
Wu PN, Chen JH, Yang CP, Hsu JC (December 2022). "Advantages of DES over BMS in Preventing the Risk of Myocardial Infarction, Ischemic Stroke, and Mortality in Various Populations". Journal of Clinical Medicine. 12 (1): 24. doi:10.3390/jcm12010024. PMC 9820891. PMID 36614825.
Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM, Bischoff JM, et al. (January 2022). "2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines". Circulation. 145 (3): e18 – e114. doi:10.1161/CIR.0000000000001038. PMID 34882435. S2CID 245072028.
Arnold SV (2018). "Current Indications for Stenting: Symptoms or Survival ^CME". Methodist DeBakey Cardiovascular Journal. 14 (1): 7–13. doi:10.14797/mdcj-14-1-7. PMC 5880567. PMID 29623167.
Fred HL (2009). "Atypical chest pain: a typical humpty dumpty coinage". Texas Heart Institute Journal. 36 (5): 373–374. PMC 2763472. PMID 19876411.
Swap CJ, Nagurney JT (November 2005). "Value and limitations of chest pain history in the evaluation of patients with suspected acute coronary syndromes". JAMA. 294 (20): 2623–2629. doi:10.1001/jama.294.20.2623. PMID 16304077.
Iwamoto Y, Okamoto M, Hashimoto M, Fukuda Y, Iwamoto A, Iwasaki T, et al. (March 2012). "Better stent expansion by two-time inflation of stent balloon and its responsible mechanism". Journal of Cardiology. 59 (2): 160–166. doi:10.1016/j.jjcc.2011.12.003. PMID 22266460.
Spadaccio C, Benedetto U (July 2018). "Coronary artery bypass grafting (CABG) vs. percutaneous coronary intervention (PCI) in the treatment of multivessel coronary disease: quo vadis? -a review of the evidences on coronary artery disease". Annals of Cardiothoracic Surgery. 7 (4): 506–515. doi:10.21037/acs.2018.05.17. PMC 6082779. PMID 30094215.
Peels JO, Hautvast RW, de Swart JB, Huybregts MA, Umans VA, Arnold AE, et al. (February 2009). "Percutaneous coronary intervention without on-site surgical back-up; two-years registry of a large Dutch community hospital". International Journal of Cardiology. 132 (1): 59–65. doi:10.1016/j.ijcard.2007.10.037. PMID 18241941.
Kirtane AJ, Stone GW (September 2011). "How to minimize stent thrombosis". Circulation. 124 (11): 1283–1287. doi:10.1161/CIRCULATIONAHA.110.976829. PMID 21911796. S2CID 17063075.
Hassan S, Ali MN, Ghafoor B (April 2022). "Evolutionary perspective of drug eluting stents: from thick polymer to polymer free approach". Journal of Cardiothoracic Surgery. 17 (1): 65. doi:10.1186/s13019-022-01812-y. PMC 8981810. PMID 35379273.
Anstrom KJ, Kong DF, Shaw LK, Califf RM, Kramer JM, Peterson ED, et al. (August 2008). "Long-term clinical outcomes following coronary stenting". Archives of Internal Medicine. 168 (15): 1647–1655. doi:10.1001/archinte.168.15.1647. PMID 18695078.
Serrano MC, Vavra AK, Jen M, Hogg ME, Murar J, Martinez J, et al. (May 2011). "Poly(diol-co-citrate)s as novel elastomeric perivascular wraps for the reduction of neointimal hyperplasia". Macromolecular Bioscience. 11 (5): 700–709. doi:10.1002/mabi.201000509. PMC 4068126. PMID 21341372.
Shlofmitz E, Ali ZA, Maehara A, Mintz GS, Shlofmitz R, Jeremias A (December 2020). "Intravascular Imaging-Guided Percutaneous Coronary Intervention: A Universal Approach for Optimization of Stent Implantation". Circulation: Cardiovascular Interventions. 13 (12): e008686. doi:10.1161/CIRCINTERVENTIONS.120.008686. PMID 33233934. S2CID 227169038.
Li M, Hou J, Gu X, Weng R, Zhong Z, Liu S (January 2022). "Incidence and risk factors of in-stent restenosis after percutaneous coronary intervention in patients from southern China". European Journal of Medical Research. 27 (1): 12. doi:10.1186/s40001-022-00640-z. PMC 8783476. PMID 35065663.
Lee MS, Shah AP, Aragon J, Jamali A, Dohad S, Kar S, et al. (December 2005). "Drug-eluting stenting is superior to bare metal stenting in saphenous vein grafts". Catheterization and Cardiovascular Interventions. 66 (4): 507–511. doi:10.1002/ccd.20498. PMID 16270361. S2CID 24315977.
Baldwin DE, Abbott JD, Trost JC, Vlachos HA, Selzer F, Glaser R, et al. (October 2010). "Comparison of drug-eluting and bare metal stents for saphenous vein graft lesions (from the National Heart, Lung, and Blood Institute Dynamic Registry)". The American Journal of Cardiology. 106 (7): 946–951. doi:10.1016/j.amjcard.2010.05.025. PMC 2945366. PMID 20854955.
Win HK, Caldera AE, Maresh K, Lopez J, Rihal CS, Parikh MA, et al. (May 2007). "Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents". JAMA. 297 (18): 2001–2009. doi:10.1001/jama.297.18.2001. PMID 17488965.
Beohar N, Davidson CJ, Kip KE, Goodreau L, Vlachos HA, Meyers SN, et al. (May 2007). "Outcomes and complications associated with off-label and untested use of drug-eluting stents". JAMA. 297 (18): 1992–2000. doi:10.1001/jama.297.18.1992. PMID 17488964.
Dixon SR, Grines CL, O'Neill WW (May 2010). "The year in interventional cardiology". Journal of the American College of Cardiology. 55 (20): 2272–86. doi:10.1016/j.jacc.2010.02.024. PMID 20466207.
Poorhosseini H, Kassaian SE, Aghajani H, Alidoosti M, Hajizeinali AM, Salarifar M, et al. (2012). "On-label and off-label use of drug-eluting stents: comparison of short- and long-term outcomes". Texas Heart Institute Journal. 39 (1): 24–29. PMC 3298939. PMID 22412223.
Song JW, Soh S, Shim JK (January 2020). "Monitored Anesthesia Care for Cardiovascular Interventions". Korean Circulation Journal. 50 (1): 1–11. doi:10.4070/kcj.2019.0269. PMC 6923237. PMID 31642214.
Shuvy M, Ko DT (28 February 2014). "Bleeding after percutaneous coronary intervention: can we still ignore the obvious?". Open Heart. 1 (1): e000036. doi:10.1136/openhrt-2014-000036. PMC 4195920. PMID 25332793.
Thibert MJ, Fordyce CB, Cairns JA, Turgeon RD, Mackay M, Lee T, et al. (July 2021). "Access-Site vs Non-Access-Site Major Bleeding and In-Hospital Outcomes Among STEMI Patients Receiving Primary PCI". CJC Open. 3 (7): 864–871. doi:10.1016/j.cjco.2021.02.009. PMC 8347846. PMID 34401693.
Canfield J, Totary-Jain H (October 2018). "40 Years of Percutaneous Coronary Intervention: History and Future Directions". Journal of Personalized Medicine. 8 (4): 33. doi:10.3390/jpm8040033. PMC 6313463. PMID 30275411.
Dalal F, Dalal HM, Voukalis C, Gandhi MM (July 2017). "Management of patients after primary percutaneous coronary intervention for myocardial infarction". BMJ. 358: j3237. doi:10.1136/bmj.j3237. PMID 28729460. S2CID 46847680.
Dangas GD, Claessen BE, Caixeta A, Sanidas EA, Mintz GS, Mehran R (November 2010). "In-stent restenosis in the drug-eluting stent era". Journal of the American College of Cardiology. 56 (23): 1897–1907. doi:10.1016/j.jacc.2010.07.028. PMID 21109112.
Bønaa KH, Mannsverk J, Wiseth R, Aaberge L, Myreng Y, Nygård O, et al. (September 2016). "Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease". The New England Journal of Medicine. 375 (13): 1242–1252. doi:10.1056/NEJMoa1607991. PMID 27572953.
Shlofmitz E, Iantorno M, Waksman R (August 2019). "Restenosis of Drug-Eluting Stents: A New Classification System Based on Disease Mechanism to Guide Treatment and State-of-the-Art Review". Circulation: Cardiovascular Interventions. 12 (8): e007023. doi:10.1161/CIRCINTERVENTIONS.118.007023. PMID 31345066. S2CID 198912657.
Palmerini T, Benedetto U, Biondi-Zoccai G, Della Riva D, Bacchi-Reggiani L, Smits PC, et al. (June 2015). "Long-Term Safety of Drug-Eluting and Bare-Metal Stents: Evidence From a Comprehensive Network Meta-Analysis". Journal of the American College of Cardiology. 65 (23): 2496–2507. doi:10.1016/j.jacc.2015.04.017. hdl:11392/2415452. PMID 26065988.
Nikam N, Steinberg TB, Steinberg DH (2014). "Advances in stent technologies and their effect on clinical efficacy and safety". Medical Devices: Evidence and Research. 7: 165–178. doi:10.2147/MDER.S31869. PMC 4051714. PMID 24940085. S2CID 5022642.
Jaiswal V, Ang SP, Shrestha AB, Joshi A, Ishak A, Chia JE, et al. (June 2023). "Percutaneous coronary intervention versus coronary artery bypass grafting among patients with left ventricular systolic dysfunction: a systematic review and meta-analysis". Annals of Medicine and Surgery. 85 (6): 2849–2857. doi:10.1097/MS9.0000000000000634. PMC 10289746. PMID 37363575.
Grüntzig AR, Senning A, Siegenthaler WE (July 1979). "Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty". The New England Journal of Medicine. 301 (2): 61–68. doi:10.1056/NEJM197907123010201. PMID 449946.
Dotter CT, Judkins MP (November 1964). "Transluminal Treatment of Arteriosclerotic Obstruction. Description of a New Technic and a Preliminary Report of Its Application". Circulation. 30 (5): 654–670. doi:10.1161/01.CIR.30.5.654. PMID 14226164.
Serruys PW, Kutryk MJ, Ong AT (February 2006). "Coronary-artery stents". The New England Journal of Medicine. 354 (5): 483–495. doi:10.1056/NEJMra051091. PMID 16452560. S2CID 13647055.
Hwang CW, Wu D, Edelman ER (July 2001). "Physiological transport forces govern drug distribution for stent-based delivery". Circulation. 104 (5): 600–605. doi:10.1161/hc3101.092214. PMID 11479260.
Mukherjee T, Shah BV (October 2005). "Sirolimus: a new immunosuppressant". J Assoc Physicians India. 53: 885–90. PMID 16459533.
Mauri L, Hsieh Wh, Massaro JM, Ho KK, D'Agostino R, Cutlip DE (8 March 2007). "Stent Thrombosis in Randomized Clinical Trials of Drug-Eluting Stents". New England Journal of Medicine. 356 (10): 1020–1029. doi:10.1056/NEJMoa067731. PMID 17296821. Archived from the original on 3 May 2023. Retrieved 8 February 2024 – via CrossRef.
Dawkins KD, Grube E, Guagliumi G, Banning AP, Zmudka K, Colombo A, et al. (22 November 2005). "Clinical Efficacy of Polymer-Based Paclitaxel-Eluting Stents in the Treatment of Complex, Long Coronary Artery Lesions From a Multicenter, Randomized Trial: Support for the Use of Drug-Eluting Stents in Contemporary Clinical Practice". Circulation. 112 (21): 3306–3313. doi:10.1161/CIRCULATIONAHA.105.552190. PMID 16286586. Archived from the original on 8 February 2024. Retrieved 8 February 2024 – via CrossRef.
Galløe AM, Thuesen L, Kelbæk H, Thayssen P, Rasmussen K, Hansen PR, et al. (30 January 2008). "Comparison of Paclitaxel- and Sirolimus-Eluting Stents in Everyday Clinical PracticeThe SORT OUT II Randomized Trial". JAMA. 299 (4): 409–416. doi:10.1001/jama.299.4.409. PMID 18230778. Archived from the original on 24 February 2024. Retrieved 8 February 2024 – via Silverchair.
Dai Y, Wang R, Chen F, Zhang Y, Liu Y, Huang H, et al. (12 November 2021). "Clinical outcomes in 2481 unselected real-world patients treated with a polymer-free sirolimus-eluting stent: 3 years results from the NANO multicenter Registry". BMC Cardiovascular Disorders. 21 (1): 537. doi:10.1186/s12872-021-02356-0. PMC 8588634. PMID 34772347.
Saito S, Bennett J, Nef HM, Webster M, Namiki A, Takahashi A, et al. (November 2023). "First randomised controlled trial comparing the sirolimus-eluting bioadaptor with the zotarolimus-eluting drug-eluting stent in patients with de novo coronary artery lesions: 12-month clinical and imaging data from the multi-centre, international, BIODAPTOR-RCT" (PDF). eClinicalMedicine. 65. doi:10.1016/j.eclinm.2023.102304. PMC 10725075. PMID 38106564. Archived (PDF) from the original on 8 February 2024. Retrieved 8 February 2024.
Uhrin P, Wang D, Mocan A, Waltenberger B, Breuss JM, Tewari D, et al. (November 2018). "Vascular smooth muscle cell proliferation as a therapeutic target. Part 2: Natural products inhibiting proliferation". Biotechnology Advances. 36 (6): 1608–1621. doi:10.1016/j.biotechadv.2018.04.002. PMID 29678389. S2CID 5027489.
Piccolo R, Bonaa KH, Efthimiou O, Varenne O, Baldo A, Urban P, et al. (June 2019). "Drug-eluting or bare-metal stents for percutaneous coronary intervention: a systematic review and individual patient data meta-analysis of randomised clinical trials - The Lancet" (PDF). The Lancet. 393 (10190): 2503–2510. doi:10.1016/S0140-6736(19)30474-X. PMID 31056295. Archived (PDF) from the original on 8 February 2024. Retrieved 8 February 2024.{{cite journal}}: CS1 maint: overridden setting (link)
Li M, Tu H, Yan Y, Guo Z, Zhu H, Niu J, et al. (21 September 2023). "Meta-analysis of outcomes from drug-eluting stent implantation in femoropopliteal arteries". PLOS ONE. 18 (9): e0291466. Bibcode:2023PLoSO..1891466L. doi:10.1371/journal.pone.0291466. PMC 10513203. PMID 37733656.
Brilakis ES, Wang TY, Rao SV, Banerjee S, Goldman S, Shunk K, et al. (2010). "Frequency and Predictors of Drug-Eluting Stent Use in Saphenous Vein Bypass Graft Percutaneous Coronary Interventions". JACC: Cardiovascular Interventions. 3 (10): 1068–1073. doi:10.1016/j.jcin.2010.07.009. PMID 20965466.
Krone RJ, Rao SV, Dai D, Anderson HV, Peterson ED, Brown MA, et al. (2010). "Acceptance, Panic, and Partial Recovery". JACC: Cardiovascular Interventions. 3 (9): 902–910. doi:10.1016/j.jcin.2010.06.014. PMID 20850088.
Ormiston JA, Serruys PW (June 2009). "Bioabsorbable coronary stents". Circulation: Cardiovascular Interventions. 2 (3): 255–260. doi:10.1161/CIRCINTERVENTIONS.109.859173. PMID 20031723.
Charpentier E, Barna A, Guillevin L, Juliard JM (2015). "Fully bioresorbable drug-eluting coronary scaffolds: A review". Archives of Cardiovascular Diseases. 108 (6–7): 385–397. doi:10.1016/j.acvd.2015.03.009. PMID 26113479.
Ni L, Chen H, Luo Z, Yu Y (28 January 2020). "Bioresorbable vascular stents and drug-eluting stents in treatment of coronary heart disease: a meta-analysis". Journal of Cardiothoracic Surgery. 15 (1): 26. doi:10.1186/s13019-020-1041-5. PMC 6986072. PMID 31992360.
Omar WA, Kumbhani DJ (2019). "The Current Literature on Bioabsorbable Stents: A Review" (PDF). Current Atherosclerosis Reports. 21 (12): 54. doi:10.1007/s11883-019-0816-4. PMID 31768641. S2CID 208278983. Archived from the original on 11 March 2024. Retrieved 11 March 2024.
Yeazel TR, Becker ML (2020). "Advancing Toward 3D Printing of Bioresorbable Shape Memory Polymer Stents". Biomacromolecules. 21 (10): 3957–3965. doi:10.1021/acs.biomac.0c01082. PMID 32924443.
Kirillova A, Yeazel TR, Asheghali D, Petersen SR, Dort S, Gall K, et al. (22 September 2021). "Fabrication of Biomedical Scaffolds Using Biodegradable Polymers". Chemical Reviews. 121 (18): 11238–11304. doi:10.1021/acs.chemrev.0c01200. PMID 33856196. Archived from the original on 13 March 2024. Retrieved 13 March 2024 – via CrossRef.
Jackson-Smith E, Zioupos S, Banerjee P (2022). "Bioresorbable vascular scaffolds versus conventional drug-eluting stents across time: A meta-analysis of randomised controlled trials". Open Heart. 9 (2): e002107. doi:10.1136/openhrt-2022-002107. PMC 9615997. PMID 36288820.
Lansky A, Wijns W, Xu B, Kelbæk H, van Royen N, Zheng M, et al. (September 2018). "Targeted therapy with a localised abluminal groove, low-dose sirolimus-eluting, biodegradable polymer coronary stent (TARGET All Comers): a multicentre, open-label, randomised non-inferiority trial". Lancet. 392 (10153): 1117–1126. doi:10.1016/S0140-6736(18)31649-0. PMID 30190206. S2CID 52169067.
Gogas BD, Farooq V, Onuma Y, Serruys PW (2012). "The ABSORB bioresorbable vascular scaffold: an evolution or revolution in interventional cardiology?" (PDF). Hellenic Journal of Cardiology. 53 (4): 301–309. PMID 22796817. Archived (PDF) from the original on 9 August 2017. Retrieved 13 January 2016.
Saito Y, Kobayashi Y (September 2023). "Contemporary coronary drug-eluting and coated stents: an updated mini-review (2023)". Cardiovascular Intervention and Therapeutics. 39 (1): 15–17. doi:10.1007/s12928-023-00954-7. PMID 37656338. S2CID 261430959.
Nicolas J, Pivato CA, Chiarito M, Beerkens F, Cao D, Mehran R (May 2023). "Evolution of drug-eluting coronary stents: a back-and-forth journey from the bench to bedside". Cardiovascular Research. 119 (3): 631–646. doi:10.1093/cvr/cvac105. PMID 35788828.
Willich SN, Müller-Riemenschneider F, McBride D, Silber S, Kuck KH, Nienaber CA, et al. (February 2012). "Health economic evaluation of the use of drug-eluting stents: First results from the Drug-Eluting Stent Registry (DES.de)". Herz. 38 (1): 57–64. doi:10.1007/s00059-012-3581-5. PMID 22301731. S2CID 25967413.
Kuukasjärvi P, Räsänen P, Malmivaara A, Aronen P, Sintonen H (2007). "Economic evaluation of drug-eluting stents: a systematic literature review and model-based cost-utility analysis". International Journal of Technology Assessment in Health Care. 23 (4): 473–479. doi:10.1017/S0266462307070560. PMID 17937836. S2CID 31846667.
Stergiopoulos K, Brown DL (February 2012). "Initial coronary stent implantation with medical therapy vs medical therapy alone for stable coronary artery disease: meta-analysis of randomized controlled trials". Archives of Internal Medicine. 172 (4): 312–319. doi:10.1001/archinternmed.2011.1484. PMID 22371919.
Kureshi F, Jones PG, Buchanan DM, Abdallah MS, Spertus JA (September 2014). "Variation in patients' perceptions of elective percutaneous coronary intervention in stable coronary artery disease: cross sectional study". BMJ. 349: g5309. doi:10.1136/bmj.g5309. PMC 4157615. PMID 25200209.

ncbi.nlm.nih.gov

Senst B, Goyal A, Basit H, Borger J (2024). "Drug Eluting Stent Compounds". StatPearls. PMID 30726034. Archived from the original on 11 March 2024. Retrieved 10 March 2024.
Velagapudi C, Madassery S (November 2022). "Drug-eluting stents". Semin Intervent Radiol. 39 (4): 400–405. doi:10.1055/s-0042-1758078. PMC 9671677. PMID 36406018.
Bin QS, Wen LS, Bo X, Jue C, Bo LH, Jin YY, et al. (September 2009). "Clinical outcomes for single stent and multiple stents in contemporary practice". Clin Cardiol. 32 (9): E33–9. doi:10.1002/clc.20516. PMC 6653171. PMID 19645042.
Niu Y, Bai N, Ma Y, Zhong P, Shang Y, Wang Z (2022). "Efficacy of intravascular imaging-guided drug-eluting stent implantation: A systematic review and meta-analysis of randomized clinical trials". BMC Cardiovascular Disorders. 22 (1): 327. doi:10.1186/s12872-022-02772-w. PMC 9308935. PMID 35870904.
Wang Y, Mintz GS, Gu Z, Qi Y, Wang Y, Liu M, et al. (2018). "Meta-analysis and systematic review of intravascular ultrasound versus angiography-guided drug eluting stent implantation in left main coronary disease in 4592 patients". BMC Cardiovascular Disorders. 18 (1): 115. doi:10.1186/s12872-018-0843-z. PMC 6001000. PMID 29898668.
Li M, Tu H, Yan Y, Guo Z, Zhu H, Niu J, et al. (2023). "Meta-analysis of outcomes from drug-eluting stent implantation in femoropopliteal arteries". PLOS ONE. 18 (9): e0291466. Bibcode:2023PLoSO..1891466L. doi:10.1371/journal.pone.0291466. PMC 10513203. PMID 37733656.
Gonzalo N, Macaya C (2012). "Absorbable stent: focus on clinical applications and benefits". Vascular Health and Risk Management. 8: 125–132. doi:10.2147/VHRM.S22551. PMC 3295634. PMID 22399857.
Pradhan A, Vishwakarma P, Vankar S, Sethi R (2019). ""The Unpredictable ABSORB" - Very Late Stent Thrombosis of Bioresorbable Vascular Scaffold". Heart Views. 20 (2): 65–69. doi:10.4103/HEARTVIEWS.HEARTVIEWS_18_19. PMC 6686611. PMID 31462962.
Lee DH, de la Torre Hernandez JM (August 2018). "The Newest Generation of Drug-eluting Stents and Beyond". European Cardiology. 13 (1): 54–59. doi:10.15420/ecr.2018:8:2 (inactive 15 January 2025). PMC 6159420. PMID 30310472. Archived from the original on 22 October 2023. Retrieved 21 October 2023.{{cite journal}}: CS1 maint: DOI inactive as of January 2025 (link)
Bozsak F, Gonzalez-Rodriguez D, Sternberger Z, Belitz P, Bewley T, Chomaz J, et al. (2015). "Optimization of Drug Delivery by Drug-Eluting Stents". PLOS ONE. 10 (6): e0130182. Bibcode:2015PLoSO..1030182B. doi:10.1371/journal.pone.0130182. PMC 4470631. PMID 26083626.
Stevens JR, Zamani A, Osborne JI, Zamani R, Akrami M (2021). "Critical evaluation of stents in coronary angioplasty: A systematic review". BioMedical Engineering OnLine. 20 (1): 46. doi:10.1186/s12938-021-00883-7. PMC 8105986. PMID 33964954.
Ye Y, Xie H, Zeng Y, Zhao X, Tian Z, Zhang S (2013). "Efficacy and Safety of Biodegradable Polymer Biolimus-Eluting Stents versus Durable Polymer Drug-Eluting Stents: A Meta-Analysis". PLOS ONE. 8 (11): e78667. Bibcode:2013PLoSO...878667Y. doi:10.1371/journal.pone.0078667. PMC 3823917. PMID 24244335.
Yuan H, Wu Z, Lu T, Wei T, Zeng Y, Liu Y, et al. (2022). "Comparison of biodegradable and durable polymer drug-eluting stents in acute coronary syndrome: A meta-analysis". BMJ Open. 12 (6): e058075. doi:10.1136/bmjopen-2021-058075. PMC 9185674. PMID 35676012. Archived from the original on 8 August 2022. Retrieved 11 March 2024.
Gao K, Sun Y, Yang M, Han L, Chen L, Hu W, et al. (2017). "Efficacy and safety of polymer-free stent versus polymer-permanent drug-eluting stent in patients with acute coronary syndrome: A meta-analysis of randomized control trials". BMC Cardiovascular Disorders. 17 (1): 194. doi:10.1186/s12872-017-0603-5. PMC 5518142. PMID 28724348.
Watson T, Webster MWI (2017). "Long and short of optimal stent design". Open Heart. 4 (2): e000680. doi:10.1136/openhrt-2017-000680. PMC 5663262. PMID 29118997.
Liu L, Liu B, Ren J, Hui G, Qi C, Wang J (2018). "Comparison of drug-eluting balloon versus drug-eluting stent for treatment of coronary artery disease: A meta-analysis of randomized controlled trials". BMC Cardiovascular Disorders. 18 (1): 46. doi:10.1186/s12872-018-0771-y. PMC 5834842. PMID 29499651.
Abdelaziz A, Hafez A, Atta K, Elsayed H, Abdelaziz M, Elaraby A, et al. (2023). "Drug-coated balloons versus drug-eluting stents in patients with acute myocardial infarction undergoing percutaneous coronary intervention: An updated meta-analysis with trial sequential analysis". BMC Cardiovascular Disorders. 23 (1): 605. doi:10.1186/s12872-023-03633-w. PMC 10709955. PMID 38066453.
Tran B (2021). "Assessment and management of peripheral arterial disease: What every cardiologist should know". Heart. 107 (22): 1835–1843. doi:10.1136/heartjnl-2019-316164. PMC 8562307. PMID 33985986. Archived from the original on 11 March 2024. Retrieved 11 March 2024.
Wei L, Leo HL, Chen Q, Li Z (2019). "Structural and Hemodynamic Analyses of Different Stent Structures in Curved and Stenotic Coronary Artery". Frontiers in Bioengineering and Biotechnology. 7: 366. doi:10.3389/fbioe.2019.00366. PMC 6908811. PMID 31867313.
Yuan H, Wu Z, Lu T, Wei T, Zeng Y, Liu Y, et al. (2022). "Comparison of biodegradable and durable polymer drug-eluting stents in acute coronary syndrome: A meta-analysis". BMJ Open. 12 (6): e058075. doi:10.1136/bmjopen-2021-058075. PMC 9185674. PMID 35676012. Archived from the original on 11 March 2024. Retrieved 11 March 2024.
Zeng Y, Xu J, Deng Y, Li X, Chen W, Tang Y (2024). "Drug-eluting stents for coronary artery disease in the perspective of bibliometric analysis". Frontiers in Cardiovascular Medicine. 11. doi:10.3389/fcvm.2024.1288659. PMC 10910058. PMID 38440210.
Bosiers M, Cagiannos C, Deloose K, Verbist J, Peeters P (2008). "Drug-eluting stents in the management of peripheral arterial disease". Vascular Health and Risk Management. 4 (3): 553–559. doi:10.2147/VHRM.S1712. PMC 2515416. PMID 18827906.
Pan C, Han Y, Lu J (2021). "Structural Design of Vascular Stents: A Review". Micromachines. 12 (7): 770. doi:10.3390/mi12070770. PMC 8305143. PMID 34210099.
Koźlik M, Harpula J, Chuchra PJ, Nowak M, Wojakowski W, Gąsior P (February 2023). "Drug-Eluting Stents: Technical and Clinical Progress". Biomimetics. 8 (1): 72. doi:10.3390/biomimetics8010072. PMC 9944483. PMID 36810403.
Ahmad M, Mehta P, Reddivari AK, Mungee S (2023). "Percutaneous Coronary Intervention". StatPearls. Treasure Island (FL): StatPearls Publishing. PMID 32310583. Archived from the original on 4 June 2023. Retrieved 21 November 2023.
Patel S, Patel KB, Patel Z, Konat A, Patel A, Doshi JS, et al. (March 2023). "Evolving Coronary Stent Technologies - A Glimpse Into the Future". Cureus. 15 (3): e35651. doi:10.7759/cureus.35651. PMC 10065169. PMID 37009355.
Wu PN, Chen JH, Yang CP, Hsu JC (December 2022). "Advantages of DES over BMS in Preventing the Risk of Myocardial Infarction, Ischemic Stroke, and Mortality in Various Populations". Journal of Clinical Medicine. 12 (1): 24. doi:10.3390/jcm12010024. PMC 9820891. PMID 36614825.
Arnold SV (2018). "Current Indications for Stenting: Symptoms or Survival ^CME". Methodist DeBakey Cardiovascular Journal. 14 (1): 7–13. doi:10.14797/mdcj-14-1-7. PMC 5880567. PMID 29623167.
Fred HL (2009). "Atypical chest pain: a typical humpty dumpty coinage". Texas Heart Institute Journal. 36 (5): 373–374. PMC 2763472. PMID 19876411.
Spadaccio C, Benedetto U (July 2018). "Coronary artery bypass grafting (CABG) vs. percutaneous coronary intervention (PCI) in the treatment of multivessel coronary disease: quo vadis? -a review of the evidences on coronary artery disease". Annals of Cardiothoracic Surgery. 7 (4): 506–515. doi:10.21037/acs.2018.05.17. PMC 6082779. PMID 30094215.
Hassan S, Ali MN, Ghafoor B (April 2022). "Evolutionary perspective of drug eluting stents: from thick polymer to polymer free approach". Journal of Cardiothoracic Surgery. 17 (1): 65. doi:10.1186/s13019-022-01812-y. PMC 8981810. PMID 35379273.
Serrano MC, Vavra AK, Jen M, Hogg ME, Murar J, Martinez J, et al. (May 2011). "Poly(diol-co-citrate)s as novel elastomeric perivascular wraps for the reduction of neointimal hyperplasia". Macromolecular Bioscience. 11 (5): 700–709. doi:10.1002/mabi.201000509. PMC 4068126. PMID 21341372.
Li M, Hou J, Gu X, Weng R, Zhong Z, Liu S (January 2022). "Incidence and risk factors of in-stent restenosis after percutaneous coronary intervention in patients from southern China". European Journal of Medical Research. 27 (1): 12. doi:10.1186/s40001-022-00640-z. PMC 8783476. PMID 35065663.
Baldwin DE, Abbott JD, Trost JC, Vlachos HA, Selzer F, Glaser R, et al. (October 2010). "Comparison of drug-eluting and bare metal stents for saphenous vein graft lesions (from the National Heart, Lung, and Blood Institute Dynamic Registry)". The American Journal of Cardiology. 106 (7): 946–951. doi:10.1016/j.amjcard.2010.05.025. PMC 2945366. PMID 20854955.
Poorhosseini H, Kassaian SE, Aghajani H, Alidoosti M, Hajizeinali AM, Salarifar M, et al. (2012). "On-label and off-label use of drug-eluting stents: comparison of short- and long-term outcomes". Texas Heart Institute Journal. 39 (1): 24–29. PMC 3298939. PMID 22412223.
Song JW, Soh S, Shim JK (January 2020). "Monitored Anesthesia Care for Cardiovascular Interventions". Korean Circulation Journal. 50 (1): 1–11. doi:10.4070/kcj.2019.0269. PMC 6923237. PMID 31642214.
Shuvy M, Ko DT (28 February 2014). "Bleeding after percutaneous coronary intervention: can we still ignore the obvious?". Open Heart. 1 (1): e000036. doi:10.1136/openhrt-2014-000036. PMC 4195920. PMID 25332793.
Thibert MJ, Fordyce CB, Cairns JA, Turgeon RD, Mackay M, Lee T, et al. (July 2021). "Access-Site vs Non-Access-Site Major Bleeding and In-Hospital Outcomes Among STEMI Patients Receiving Primary PCI". CJC Open. 3 (7): 864–871. doi:10.1016/j.cjco.2021.02.009. PMC 8347846. PMID 34401693.
Canfield J, Totary-Jain H (October 2018). "40 Years of Percutaneous Coronary Intervention: History and Future Directions". Journal of Personalized Medicine. 8 (4): 33. doi:10.3390/jpm8040033. PMC 6313463. PMID 30275411.
Nikam N, Steinberg TB, Steinberg DH (2014). "Advances in stent technologies and their effect on clinical efficacy and safety". Medical Devices: Evidence and Research. 7: 165–178. doi:10.2147/MDER.S31869. PMC 4051714. PMID 24940085. S2CID 5022642.
Jaiswal V, Ang SP, Shrestha AB, Joshi A, Ishak A, Chia JE, et al. (June 2023). "Percutaneous coronary intervention versus coronary artery bypass grafting among patients with left ventricular systolic dysfunction: a systematic review and meta-analysis". Annals of Medicine and Surgery. 85 (6): 2849–2857. doi:10.1097/MS9.0000000000000634. PMC 10289746. PMID 37363575.
Dai Y, Wang R, Chen F, Zhang Y, Liu Y, Huang H, et al. (12 November 2021). "Clinical outcomes in 2481 unselected real-world patients treated with a polymer-free sirolimus-eluting stent: 3 years results from the NANO multicenter Registry". BMC Cardiovascular Disorders. 21 (1): 537. doi:10.1186/s12872-021-02356-0. PMC 8588634. PMID 34772347.
Saito S, Bennett J, Nef HM, Webster M, Namiki A, Takahashi A, et al. (November 2023). "First randomised controlled trial comparing the sirolimus-eluting bioadaptor with the zotarolimus-eluting drug-eluting stent in patients with de novo coronary artery lesions: 12-month clinical and imaging data from the multi-centre, international, BIODAPTOR-RCT" (PDF). eClinicalMedicine. 65. doi:10.1016/j.eclinm.2023.102304. PMC 10725075. PMID 38106564. Archived (PDF) from the original on 8 February 2024. Retrieved 8 February 2024.
Li M, Tu H, Yan Y, Guo Z, Zhu H, Niu J, et al. (21 September 2023). "Meta-analysis of outcomes from drug-eluting stent implantation in femoropopliteal arteries". PLOS ONE. 18 (9): e0291466. Bibcode:2023PLoSO..1891466L. doi:10.1371/journal.pone.0291466. PMC 10513203. PMID 37733656.
Ni L, Chen H, Luo Z, Yu Y (28 January 2020). "Bioresorbable vascular stents and drug-eluting stents in treatment of coronary heart disease: a meta-analysis". Journal of Cardiothoracic Surgery. 15 (1): 26. doi:10.1186/s13019-020-1041-5. PMC 6986072. PMID 31992360.
Jackson-Smith E, Zioupos S, Banerjee P (2022). "Bioresorbable vascular scaffolds versus conventional drug-eluting stents across time: A meta-analysis of randomised controlled trials". Open Heart. 9 (2): e002107. doi:10.1136/openhrt-2022-002107. PMC 9615997. PMID 36288820.
Kureshi F, Jones PG, Buchanan DM, Abdallah MS, Spertus JA (September 2014). "Variation in patients' perceptions of elective percutaneous coronary intervention in stable coronary artery disease: cross sectional study". BMJ. 349: g5309. doi:10.1136/bmj.g5309. PMC 4157615. PMID 25200209.

nhlbi.nih.gov

"Stents - What to Expect After Getting a Stent | NHLBI, NIH". www.nhlbi.nih.gov. 24 March 2022. Archived from the original on 21 November 2023. Retrieved 21 November 2023.
"Stents - Living With a Stent | NHLBI, NIH". www.nhlbi.nih.gov. 24 March 2022. Archived from the original on 21 November 2023. Retrieved 21 November 2023.

nytimes.com

Bakalar N (27 February 2012). "No Extra Benefits Are Seen in Stents for Coronary Artery Disease". The New York Times. ISSN 0362-4331. Archived from the original on 24 November 2023. Retrieved 24 November 2023.
Kolata G (16 November 2019). "Surgery for Blocked Arteries Is Often Unwarranted, Researchers Find". The New York Times. ISSN 0362-4331. Archived from the original on 29 December 2022. Retrieved 24 November 2023.
"Patients Before Profits (1 Letter)". The New York Times. 5 March 2012. ISSN 0362-4331. Archived from the original on 24 November 2023. Retrieved 24 November 2023.

archive.nytimes.com

"Expert Answers on E.M.D.R." Consults Blog. The New York Times. 16 March 2012. Archived from the original on 21 January 2024. Retrieved 24 November 2023.

radiologyinfo.org

Radiological Society of North America (RSNA), American College of Radiology (ACR). "Angioplasty and Vascular Stenting". Radiologyinfo.org. Archived from the original on 21 November 2023. Retrieved 21 November 2023.

researchandmarkets.com

"Drug-Eluting Stents Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028". Research and Markets Ltd. Archived from the original on 24 November 2023. Retrieved 24 November 2023.

scai.org

"New Statement Shows PCI Without Surgery on Site Is as Safe as PCI With Surgery on Site". Society for Cardiovascular Angiography & Interventions (SCAI). Archived from the original on 23 November 2023. Retrieved 23 November 2023.

schmidtlaw.com

"Heart Stent Class Action Lawsuit". The Schmidt Firm, PLLC. Archived from the original on 24 November 2023. Retrieved 24 November 2023.

semanticscholar.org

api.semanticscholar.org

Iqbal J, Gunn J, Serruys PW (2013). "Coronary stents: historical development, current status and future directions". British Medical Bulletin. 106: 193–211. doi:10.1093/bmb/ldt009. PMID 23532779. S2CID 14423973.
Chen K, Xu L, Liu X (2024). "Different drugs in drug-eluting stents for peripheral artery disease: A systematic evaluation and Bayesian meta-analysis". Journal of Thrombosis and Thrombolysis. 57 (3): 520–530. doi:10.1007/s11239-023-02932-5. PMID 38281227. S2CID 267309550. Archived from the original on 11 March 2024. Retrieved 11 March 2024.
Hanawa T (1 June 2009). "Materials for metallic stents". Journal of Artificial Organs. 12 (2): 73–79. doi:10.1007/s10047-008-0456-x. PMID 19536623. S2CID 20660118.
Saito Y, Kobayashi Y (2024). "Contemporary coronary drug-eluting and coated stents: An updated mini-review (2023)". Cardiovascular Intervention and Therapeutics. 39 (1): 15–17. doi:10.1007/s12928-023-00954-7. PMID 37656338. S2CID 261430959. Archived from the original on 24 November 2023. Retrieved 11 March 2024.
Coronary Artery Disease and the Evolution of Angioplasty Devices. SpringerBriefs in Materials. 2020. doi:10.1007/978-3-030-42443-5. ISBN 978-3-030-42442-8. S2CID 218682351. Archived from the original on 11 March 2024. Retrieved 11 March 2024.
Al Suwaidi J, Berger PB, Holmes Jr DR (2000). "Coronary Artery Stents". JAMA. 284 (14): 1828–1836. doi:10.1001/jama.284.14.1828. PMID 11025836. S2CID 31919688. Archived from the original on 17 June 2022. Retrieved 11 March 2024.
Majewska P, Oledzka E, Sobczak M (January 2020). "Overview of the latest developments in the field of drug-eluting stent technology". Biomater Sci. 8 (2): 544–551. doi:10.1039/c9bm00468h. PMID 31701961. S2CID 207966529.
Yasmin F, Jawed K, Moeed A, Ali SH (January 2024). "Efficacy of Intravascular Imaging-Guided Drug-Eluting Stent Implantation: A Systematic Review and Meta-Analysis of Randomized Clinical Trials". Curr Probl Cardiol. 49 (1 Pt A): 102002. doi:10.1016/j.cpcardiol.2023.102002. PMID 37544623. S2CID 260681557.
Waksman R (December 2017). "A new generation of drug-eluting stents: Indications and outcomes of bioresorbable vascular scaffolds". Cleveland Clinic Journal of Medicine. 84 (12 Suppl 4): e20 – e24. doi:10.3949/ccjm.84.s4.05. PMID 29281608. S2CID 3663635.
Cutlip DE (15 February 2017). "Dual Anti-platelet Therapy after Coronary Stenting: Rationale for Personalized Duration of Therapy". US Cardiol Rev. 11: 31–36. doi:10.15420/usc.2017:7:2. S2CID 108846490. Archived from the original on 20 November 2023. Retrieved 20 November 2023.
Slavin L, Chhabra A, Tobis JM (2007). "Drug-eluting stents: preventing restenosis". Cardiology in Review. 15 (1): 1–12. doi:10.1097/01.crd.0000200844.16899.fc. PMID 17172878. S2CID 24548420.
George S, Butler R, Nolan J, Mamas MA (30 June 2016). "Percutaneous Coronary Intervention and Bleeding Complications". EMJ Interventional Cardiology. 4 (1): 100–109. doi:10.33590/emjintcardiol/10314557. ISSN 2053-423X. S2CID 256147538. Archived from the original on 19 November 2023. Retrieved 19 November 2023.
Habib A, Mori H, Yahagi K, Finn AV (3 February 2017). "Contemporary Drug-Eluting Stents and Vascular Response". EMJ Interventional Cardiology. 2 (1): 60–68. doi:10.33590/emj/10314324. ISSN 2053-423X. S2CID 13713278. Archived from the original on 5 November 2023. Retrieved 5 November 2023.
Piccolo R, Bonaa KH, Efthimiou O, Varenne O, Baldo A, Urban P, et al. (June 2019). "Drug-eluting or bare-metal stents for percutaneous coronary intervention: a systematic review and individual patient data meta-analysis of randomised clinical trials". Lancet. 393 (10190): 2503–2510. doi:10.1016/S0140-6736(19)30474-X. PMID 31056295. S2CID 144207970.
Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM, Bischoff JM, et al. (January 2022). "2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines". Circulation. 145 (3): e18 – e114. doi:10.1161/CIR.0000000000001038. PMID 34882435. S2CID 245072028.
Kirtane AJ, Stone GW (September 2011). "How to minimize stent thrombosis". Circulation. 124 (11): 1283–1287. doi:10.1161/CIRCULATIONAHA.110.976829. PMID 21911796. S2CID 17063075.
Shlofmitz E, Ali ZA, Maehara A, Mintz GS, Shlofmitz R, Jeremias A (December 2020). "Intravascular Imaging-Guided Percutaneous Coronary Intervention: A Universal Approach for Optimization of Stent Implantation". Circulation: Cardiovascular Interventions. 13 (12): e008686. doi:10.1161/CIRCINTERVENTIONS.120.008686. PMID 33233934. S2CID 227169038.
Lee MS, Shah AP, Aragon J, Jamali A, Dohad S, Kar S, et al. (December 2005). "Drug-eluting stenting is superior to bare metal stenting in saphenous vein grafts". Catheterization and Cardiovascular Interventions. 66 (4): 507–511. doi:10.1002/ccd.20498. PMID 16270361. S2CID 24315977.
Dalal F, Dalal HM, Voukalis C, Gandhi MM (July 2017). "Management of patients after primary percutaneous coronary intervention for myocardial infarction". BMJ. 358: j3237. doi:10.1136/bmj.j3237. PMID 28729460. S2CID 46847680.
Shlofmitz E, Iantorno M, Waksman R (August 2019). "Restenosis of Drug-Eluting Stents: A New Classification System Based on Disease Mechanism to Guide Treatment and State-of-the-Art Review". Circulation: Cardiovascular Interventions. 12 (8): e007023. doi:10.1161/CIRCINTERVENTIONS.118.007023. PMID 31345066. S2CID 198912657.
Nikam N, Steinberg TB, Steinberg DH (2014). "Advances in stent technologies and their effect on clinical efficacy and safety". Medical Devices: Evidence and Research. 7: 165–178. doi:10.2147/MDER.S31869. PMC 4051714. PMID 24940085. S2CID 5022642.
Serruys PW, Kutryk MJ, Ong AT (February 2006). "Coronary-artery stents". The New England Journal of Medicine. 354 (5): 483–495. doi:10.1056/NEJMra051091. PMID 16452560. S2CID 13647055.
Uhrin P, Wang D, Mocan A, Waltenberger B, Breuss JM, Tewari D, et al. (November 2018). "Vascular smooth muscle cell proliferation as a therapeutic target. Part 2: Natural products inhibiting proliferation". Biotechnology Advances. 36 (6): 1608–1621. doi:10.1016/j.biotechadv.2018.04.002. PMID 29678389. S2CID 5027489.
Aljihmani L, Alic L, Boudjemline Y, Hijazi ZM, Mansoor B, Serpedin E, et al. (2019). "Magnesium-Based Bioresorbable Stent Materials: Review of Reviews". Journal of Bio- and Tribo-Corrosion. 5 (1): 26. Bibcode:2019JBTC....5...26A. doi:10.1007/s40735-019-0216-x. S2CID 80811999. Archived from the original on 11 March 2024. Retrieved 11 March 2024.
Omar WA, Kumbhani DJ (2019). "The Current Literature on Bioabsorbable Stents: A Review" (PDF). Current Atherosclerosis Reports. 21 (12): 54. doi:10.1007/s11883-019-0816-4. PMID 31768641. S2CID 208278983. Archived from the original on 11 March 2024. Retrieved 11 March 2024.
Lansky A, Wijns W, Xu B, Kelbæk H, van Royen N, Zheng M, et al. (September 2018). "Targeted therapy with a localised abluminal groove, low-dose sirolimus-eluting, biodegradable polymer coronary stent (TARGET All Comers): a multicentre, open-label, randomised non-inferiority trial". Lancet. 392 (10153): 1117–1126. doi:10.1016/S0140-6736(18)31649-0. PMID 30190206. S2CID 52169067.
Saito Y, Kobayashi Y (September 2023). "Contemporary coronary drug-eluting and coated stents: an updated mini-review (2023)". Cardiovascular Intervention and Therapeutics. 39 (1): 15–17. doi:10.1007/s12928-023-00954-7. PMID 37656338. S2CID 261430959.
Willich SN, Müller-Riemenschneider F, McBride D, Silber S, Kuck KH, Nienaber CA, et al. (February 2012). "Health economic evaluation of the use of drug-eluting stents: First results from the Drug-Eluting Stent Registry (DES.de)". Herz. 38 (1): 57–64. doi:10.1007/s00059-012-3581-5. PMID 22301731. S2CID 25967413.
Kuukasjärvi P, Räsänen P, Malmivaara A, Aronen P, Sintonen H (2007). "Economic evaluation of drug-eluting stents: a systematic literature review and model-based cost-utility analysis". International Journal of Technology Assessment in Health Care. 23 (4): 473–479. doi:10.1017/S0266462307070560. PMID 17937836. S2CID 31846667.

springer.com

link.springer.com

Chen K, Xu L, Liu X (2024). "Different drugs in drug-eluting stents for peripheral artery disease: A systematic evaluation and Bayesian meta-analysis". Journal of Thrombosis and Thrombolysis. 57 (3): 520–530. doi:10.1007/s11239-023-02932-5. PMID 38281227. S2CID 267309550. Archived from the original on 11 March 2024. Retrieved 11 March 2024.
Saito Y, Kobayashi Y (2024). "Contemporary coronary drug-eluting and coated stents: An updated mini-review (2023)". Cardiovascular Intervention and Therapeutics. 39 (1): 15–17. doi:10.1007/s12928-023-00954-7. PMID 37656338. S2CID 261430959. Archived from the original on 24 November 2023. Retrieved 11 March 2024.
Mao H, Bao J (2018). "Peripheral Stent". In Jing Z, Mao H (eds.). Endovascular Surgery and Devices. Springer. pp. 43–57. doi:10.1007/978-981-10-8270-2_5. ISBN 978-981-10-8270-2. Retrieved 5 March 2024.
Aljihmani L, Alic L, Boudjemline Y, Hijazi ZM, Mansoor B, Serpedin E, et al. (2019). "Magnesium-Based Bioresorbable Stent Materials: Review of Reviews". Journal of Bio- and Tribo-Corrosion. 5 (1): 26. Bibcode:2019JBTC....5...26A. doi:10.1007/s40735-019-0216-x. S2CID 80811999. Archived from the original on 11 March 2024. Retrieved 11 March 2024.
Witte F, Eliezer A (2012). "Biodegradable Metals". Degradation of Implant Materials. Springer. pp. 93–109. doi:10.1007/978-1-4614-3942-4_5. ISBN 978-1-4614-3941-7. Archived from the original on 18 June 2018. Retrieved 11 March 2024.
Omar WA, Kumbhani DJ (2019). "The Current Literature on Bioabsorbable Stents: A Review" (PDF). Current Atherosclerosis Reports. 21 (12): 54. doi:10.1007/s11883-019-0816-4. PMID 31768641. S2CID 208278983. Archived from the original on 11 March 2024. Retrieved 11 March 2024.
Malmonge SM, Cliquet C (2023). "Fully Bioresorbable Vascular Stents". Current Trends in Biomedical Engineering. Springer. pp. 255–268. doi:10.1007/978-3-031-38743-2_14. ISBN 978-3-031-38742-5. Archived from the original on 11 March 2024. Retrieved 11 March 2024.

terumois.com

"TR BAND® Radial Compression Device". www.terumois.com. Archived from the original on 22 October 2023. Retrieved 21 October 2023.

thelancet.com

Saito S, Bennett J, Nef HM, Webster M, Namiki A, Takahashi A, et al. (November 2023). "First randomised controlled trial comparing the sirolimus-eluting bioadaptor with the zotarolimus-eluting drug-eluting stent in patients with de novo coronary artery lesions: 12-month clinical and imaging data from the multi-centre, international, BIODAPTOR-RCT" (PDF). eClinicalMedicine. 65. doi:10.1016/j.eclinm.2023.102304. PMC 10725075. PMID 38106564. Archived (PDF) from the original on 8 February 2024. Retrieved 8 February 2024.
Piccolo R, Bonaa KH, Efthimiou O, Varenne O, Baldo A, Urban P, et al. (June 2019). "Drug-eluting or bare-metal stents for percutaneous coronary intervention: a systematic review and individual patient data meta-analysis of randomised clinical trials - The Lancet" (PDF). The Lancet. 393 (10190): 2503–2510. doi:10.1016/S0140-6736(19)30474-X. PMID 31056295. Archived (PDF) from the original on 8 February 2024. Retrieved 8 February 2024.{{cite journal}}: CS1 maint: overridden setting (link)

uptodate.com

"UpToDate". Archived from the original on 20 November 2023. Retrieved 15 March 2024.
Aroesty JM (19 June 2023). Cutlip D, Parikh N (eds.). "Patient education: Stenting for the heart (Beyond the Basics)". UpToDate. Archived from the original on 23 November 2023. Retrieved 23 November 2023.

uscjournal.com

Cutlip DE (15 February 2017). "Dual Anti-platelet Therapy after Coronary Stenting: Rationale for Personalized Duration of Therapy". US Cardiol Rev. 11: 31–36. doi:10.15420/usc.2017:7:2. S2CID 108846490. Archived from the original on 20 November 2023. Retrieved 20 November 2023.

uspharmacist.com

Cassagnol M, Maha S. "Drug-Eluting Stents". www.uspharmacist.com. Archived from the original on 21 November 2023. Retrieved 21 November 2023.

web.archive.org

"Stent: MedlinePlus Medical Encyclopedia". Archived from the original on 5 July 2016. Retrieved 10 March 2024.
"Drug-Eluting Stents Information". Archived from the original on 10 March 2024. Retrieved 10 March 2024.
Senst B, Goyal A, Basit H, Borger J (2024). "Drug Eluting Stent Compounds". StatPearls. PMID 30726034. Archived from the original on 11 March 2024. Retrieved 10 March 2024.
Stone G (2006). "Drug-eluting Stents - Current and Future Perspectives". Interventional Cardiology. 1 (1): 28–29. doi:10.15420/icr.2006.1.1.28. Archived from the original on 20 November 2023. Retrieved 20 November 2023.
"Onyx Frontier DES - Coronary Stents". Medtronic. Archived from the original on 19 November 2023. Retrieved 23 November 2023.
"Promus PREMIER™ Drug-Eluting Coronary Stent System". www.bostonscientific.com. Archived from the original on 23 November 2023. Retrieved 23 November 2023.
Chen K, Xu L, Liu X (2024). "Different drugs in drug-eluting stents for peripheral artery disease: A systematic evaluation and Bayesian meta-analysis". Journal of Thrombosis and Thrombolysis. 57 (3): 520–530. doi:10.1007/s11239-023-02932-5. PMID 38281227. S2CID 267309550. Archived from the original on 11 March 2024. Retrieved 11 March 2024.
Lee DH, de la Torre Hernandez JM (August 2018). "The Newest Generation of Drug-eluting Stents and Beyond". European Cardiology. 13 (1): 54–59. doi:10.15420/ecr.2018:8:2 (inactive 15 January 2025). PMC 6159420. PMID 30310472. Archived from the original on 22 October 2023. Retrieved 21 October 2023.{{cite journal}}: CS1 maint: DOI inactive as of January 2025 (link)
Yuan H, Wu Z, Lu T, Wei T, Zeng Y, Liu Y, et al. (2022). "Comparison of biodegradable and durable polymer drug-eluting stents in acute coronary syndrome: A meta-analysis". BMJ Open. 12 (6): e058075. doi:10.1136/bmjopen-2021-058075. PMC 9185674. PMID 35676012. Archived from the original on 8 August 2022. Retrieved 11 March 2024.
Saito Y, Kobayashi Y (2024). "Contemporary coronary drug-eluting and coated stents: An updated mini-review (2023)". Cardiovascular Intervention and Therapeutics. 39 (1): 15–17. doi:10.1007/s12928-023-00954-7. PMID 37656338. S2CID 261430959. Archived from the original on 24 November 2023. Retrieved 11 March 2024.
McClean DR, Eigler NL (20 November 2002). "Stent Design: Implications for Restenosis". Reviews in Cardiovascular Medicine. 3 (S5): 16–22. Archived from the original on 8 December 2023. Retrieved 11 March 2024.
Coronary Artery Disease and the Evolution of Angioplasty Devices. SpringerBriefs in Materials. 2020. doi:10.1007/978-3-030-42443-5. ISBN 978-3-030-42442-8. S2CID 218682351. Archived from the original on 11 March 2024. Retrieved 11 March 2024.
McCormick C (2018). "Overview of cardiovascular stent designs". Functionalised Cardiovascular Stents. pp. 3–26. doi:10.1016/B978-0-08-100496-8.00001-9. ISBN 978-0-08-100496-8. Archived from the original on 11 March 2024. Retrieved 11 March 2024.
Murphy G, Naughton A, Durand R, Heron E, McCaughey C, Murphy R, et al. (2022). "50 Drug-eluting balloons and drug-eluting stents in the treatment of small coronary arteries: A systematic review and meta-analysis of long-term clinical outcomes". General posters. pp. A43 – A46. doi:10.1136/heartjnl-2022-ICS.50. Archived from the original on 11 March 2024. Retrieved 11 March 2024.
Jain KK (2011). "Coronary Angioplasty and Drug-Eluting Stents". Applications of Biotechnology in Cardiovascular Therapeutics. pp. 259–313. doi:10.1007/978-1-61779-240-3_9. ISBN 978-1-61779-239-7. Archived from the original on 11 March 2024. Retrieved 11 March 2024.
"Percutaneous Coronary Intervention (PCI)". Yale Medicine. Archived from the original on 22 October 2023. Retrieved 21 October 2023.
Medtronic. "Onyx Frontier DES - Coronary Stents". www.medtronic.com. Archived from the original on 19 November 2023. Retrieved 19 November 2023.
Oliva G, Espallargues M, Pons JM (2004). "Antiproliferative Drug-Eluting Stents: Systematic Review of the Benefits and Estimate of Economic Impact". Revista Española de Cardiología (English Edition). 57 (7): 617–628. doi:10.1016/S1885-5857(06)60285-5. PMID 15274846. Archived from the original on 11 March 2024. Retrieved 11 March 2024.
Hill R, Dündar Y, Bakhai A, Dickson R, Walley T (2004). "Drug-eluting stents: An early systematic review to inform policy*1, *2". European Heart Journal. 25 (11): 902–919. doi:10.1016/j.ehj.2004.03.023. PMID 15172462. Archived from the original on 11 March 2024. Retrieved 11 March 2024.
Cassagnol M, Maha S. "Drug-Eluting Stents". www.uspharmacist.com. Archived from the original on 21 November 2023. Retrieved 21 November 2023.
Tran B (2021). "Assessment and management of peripheral arterial disease: What every cardiologist should know". Heart. 107 (22): 1835–1843. doi:10.1136/heartjnl-2019-316164. PMC 8562307. PMID 33985986. Archived from the original on 11 March 2024. Retrieved 11 March 2024.
Al Suwaidi J, Berger PB, Holmes Jr DR (2000). "Coronary Artery Stents". JAMA. 284 (14): 1828–1836. doi:10.1001/jama.284.14.1828. PMID 11025836. S2CID 31919688. Archived from the original on 17 June 2022. Retrieved 11 March 2024.
Yuan H, Wu Z, Lu T, Wei T, Zeng Y, Liu Y, et al. (2022). "Comparison of biodegradable and durable polymer drug-eluting stents in acute coronary syndrome: A meta-analysis". BMJ Open. 12 (6): e058075. doi:10.1136/bmjopen-2021-058075. PMC 9185674. PMID 35676012. Archived from the original on 11 March 2024. Retrieved 11 March 2024.
"Atherosclerosis | Description, Pathophysiology, Risk Factors, & Treatment | Britannica". 13 March 2024. Archived from the original on 13 February 2024. Retrieved 15 March 2024.
Serruys PW, Kutryk MJ, Ong AT (2 February 2006). "Coronary-Artery Stents". New England Journal of Medicine. 354 (5): 483–495. doi:10.1056/NEJMra051091. PMID 16452560. Archived from the original on 15 October 2022. Retrieved 15 March 2024.
Katib N, Varcoe RL (2023). "Intervention for chronic lower limb ischemia". In Loftus I, Hinchliffe RJ (eds.). Vascular and Endovascular Surgery (7th ed.). Elsevier Health Sciences. pp. 39–57. ISBN 978-0-7020-8463-8. Archived from the original on 16 March 2024. Retrieved 4 March 2024.
Cutlip DE (15 February 2017). "Dual Anti-platelet Therapy after Coronary Stenting: Rationale for Personalized Duration of Therapy". US Cardiol Rev. 11: 31–36. doi:10.15420/usc.2017:7:2. S2CID 108846490. Archived from the original on 20 November 2023. Retrieved 20 November 2023.
Dehmer GJ, Smith KJ (December 2009). "Drug-Eluting Coronary Artery Stents". American Family Physician. 80 (11): 1245–1251. PMID 19961137. Archived from the original on 30 November 2023. Retrieved 15 March 2024.
"UpToDate". Archived from the original on 20 November 2023. Retrieved 15 March 2024.
George S, Butler R, Nolan J, Mamas MA (30 June 2016). "Percutaneous Coronary Intervention and Bleeding Complications". EMJ Interventional Cardiology. 4 (1): 100–109. doi:10.33590/emjintcardiol/10314557. ISSN 2053-423X. S2CID 256147538. Archived from the original on 19 November 2023. Retrieved 19 November 2023.
Ahmad M, Mehta P, Reddivari AK, Mungee S (2023). "Percutaneous Coronary Intervention". StatPearls. Treasure Island (FL): StatPearls Publishing. PMID 32310583. Archived from the original on 4 June 2023. Retrieved 21 November 2023.
"Percutaneous Coronary Intervention (PCI)". Yale Medicine. Archived from the original on 22 October 2023. Retrieved 21 November 2023.
Habib A, Mori H, Yahagi K, Finn AV (3 February 2017). "Contemporary Drug-Eluting Stents and Vascular Response". EMJ Interventional Cardiology. 2 (1): 60–68. doi:10.33590/emj/10314324. ISSN 2053-423X. S2CID 13713278. Archived from the original on 5 November 2023. Retrieved 5 November 2023.
"Coronary Artery Disease". U.S. Centers for Disease Control and Prevention (CDC). 19 July 2021. Archived from the original on 2 March 2015. Retrieved 24 November 2023.
Aroesty JM (19 June 2023). Cutlip D, Parikh N (eds.). "Patient education: Stenting for the heart (Beyond the Basics)". UpToDate. Archived from the original on 23 November 2023. Retrieved 23 November 2023.
Clark W, Burnes J (18 August 2016). "Angioplasty and Stent Insertion". InsideRadiology. Archived from the original on 29 November 2023. Retrieved 23 November 2023.
"New Statement Shows PCI Without Surgery on Site Is as Safe as PCI With Surgery on Site". Society for Cardiovascular Angiography & Interventions (SCAI). Archived from the original on 23 November 2023. Retrieved 23 November 2023.
Toleos A (31 October 2023). "PRESS RELEASE: Unnecessary coronary stents cost Medicare as much as $800 million per year". Lown Institute. Archived from the original on 3 November 2023. Retrieved 3 November 2023.
"Avoiding Overuse: Coronary Stents". Lown Institute Hospital Index. Archived from the original on 15 November 2023. Retrieved 21 November 2023.
"Percutaneous coronary intervention". Heart and Stroke Foundation of Canada. Archived from the original on 23 November 2023. Retrieved 23 November 2023.
Stouffer III GA, Yadav PK, Todd JW, Yousuf MA (27 November 2019). Peter K (ed.). "Percutaneous Coronary Intervention (PCI) Technique: Access, Procedure, Anatomic and Physiologic Assessment". emedicine.medscape.com. Archived from the original on 13 November 2023. Retrieved 21 November 2023.
"TR BAND® Radial Compression Device". www.terumois.com. Archived from the original on 22 October 2023. Retrieved 21 October 2023.
"Onyx Frontier DES - Coronary Stents". Medtronic. Archived from the original on 19 November 2023. Retrieved 19 November 2023.
"IVUS in PCI Guidance". American College of Cardiology. Archived from the original on 24 November 2023. Retrieved 21 November 2023.
Center for Devices and RadiologicalHealth (15 August 2023). "Fluoroscopy". FDA. Archived from the original on 11 November 2023. Retrieved 21 November 2023.
Goergen S (13 September 2016). "Iodine-containing contrast medium". InsideRadiology. Archived from the original on 7 July 2022. Retrieved 21 November 2023.
Radiological Society of North America (RSNA), American College of Radiology (ACR). "Angioplasty and Vascular Stenting". Radiologyinfo.org. Archived from the original on 21 November 2023. Retrieved 21 November 2023.
"Short Hospital Stays After Angioplasty Following Heart Attack Often Sufficient". American College of Cardiology. Archived from the original on 24 February 2024. Retrieved 21 November 2023.
"Coronary angioplasty and stents (PCI)". British Heart Foundation. Archived from the original on 21 November 2023. Retrieved 21 November 2023.
"Stents - What to Expect After Getting a Stent | NHLBI, NIH". www.nhlbi.nih.gov. 24 March 2022. Archived from the original on 21 November 2023. Retrieved 21 November 2023.
"Coronary angioplasty and stent insertion - Recovery". nhs.uk. 11 June 2018. Archived from the original on 24 December 2021. Retrieved 21 November 2023.
"Discharge advice after your coronary angiogram, angioplasty or stent insertion (PCI)". Hull University Teaching Hospitals NHS Trust. 9 April 2021. Archived from the original on 21 November 2023. Retrieved 21 November 2023.
"Stents - Living With a Stent | NHLBI, NIH". www.nhlbi.nih.gov. 24 March 2022. Archived from the original on 21 November 2023. Retrieved 21 November 2023.
"How Cardiac Rehabilitation Can Help Heal Your Heart". U.S. Centers for Disease Control and Prevention. 12 September 2022. Archived from the original on 27 November 2023. Retrieved 21 November 2023.
Yalcin D (29 November 2019). "Mechanical Testing of Vascular Stents". ADMET. Archived from the original on 23 November 2023. Retrieved 23 November 2023.
"Overview of Medical Device Classification and Reclassification". FDA. 3 November 2018. Archived from the original on 19 November 2023. Retrieved 19 November 2023.
Ellis SG, Holme DR (2006). Strategic Approaches in Coronary Intervention. Lippincott Williams & Wilkins. ISBN 978-0-7817-4294-8. Archived from the original on 20 October 2023. Retrieved 13 May 2015.
"Guideline on the development of medicinal substances contained in drug-eluting (medicinal substance-eluting) coronary stents" (PDF). London: European Medicines Agency. 22 March 2007. Archived (PDF) from the original on 8 February 2024. Retrieved 8 February 2024.
"Sirolimus-Eluting Stents for Chronic Total Coronary Occlusions - Full Text View - ClinicalTrials.gov". clinicaltrials.gov. 5 March 2007. Archived from the original on 13 April 2021. Retrieved 8 February 2024.
"Sirolimus-eluting Stents With Biodegradable Polymer Versus an Everolimus-eluting Stents - Full Text View - ClinicalTrials.gov". clinicaltrials.gov. 16 October 2018. Archived from the original on 15 May 2021. Retrieved 8 February 2024.
"Clinical Trial on the Efficacy and Safety of Sirolimus-Eluting Stent (MiStent® System) - Full Text View - ClinicalTrials.gov". clinicaltrials.gov. 3 September 2020. Archived from the original on 7 April 2021. Retrieved 8 February 2024.
Mauri L, Hsieh Wh, Massaro JM, Ho KK, D'Agostino R, Cutlip DE (8 March 2007). "Stent Thrombosis in Randomized Clinical Trials of Drug-Eluting Stents". New England Journal of Medicine. 356 (10): 1020–1029. doi:10.1056/NEJMoa067731. PMID 17296821. Archived from the original on 3 May 2023. Retrieved 8 February 2024 – via CrossRef.
"A Randomized, Double-blind Study to Assess Paclitaxel-eluting Stents in Treatment of Longer Lesions - Full Text View - ClinicalTrials.gov". clinicaltrials.gov. Archived from the original on 6 April 2021. Retrieved 8 February 2024.
Dawkins KD, Grube E, Guagliumi G, Banning AP, Zmudka K, Colombo A, et al. (22 November 2005). "Clinical Efficacy of Polymer-Based Paclitaxel-Eluting Stents in the Treatment of Complex, Long Coronary Artery Lesions From a Multicenter, Randomized Trial: Support for the Use of Drug-Eluting Stents in Contemporary Clinical Practice". Circulation. 112 (21): 3306–3313. doi:10.1161/CIRCULATIONAHA.105.552190. PMID 16286586. Archived from the original on 8 February 2024. Retrieved 8 February 2024 – via CrossRef.
"Clinical Trial Results - Eluvia Drug-Eluting Stent". www.bostonscientific.com. Archived from the original on 8 February 2024. Retrieved 8 February 2024.
Galløe AM, Thuesen L, Kelbæk H, Thayssen P, Rasmussen K, Hansen PR, et al. (30 January 2008). "Comparison of Paclitaxel- and Sirolimus-Eluting Stents in Everyday Clinical PracticeThe SORT OUT II Randomized Trial". JAMA. 299 (4): 409–416. doi:10.1001/jama.299.4.409. PMID 18230778. Archived from the original on 24 February 2024. Retrieved 8 February 2024 – via Silverchair.
Saito S, Bennett J, Nef HM, Webster M, Namiki A, Takahashi A, et al. (November 2023). "First randomised controlled trial comparing the sirolimus-eluting bioadaptor with the zotarolimus-eluting drug-eluting stent in patients with de novo coronary artery lesions: 12-month clinical and imaging data from the multi-centre, international, BIODAPTOR-RCT" (PDF). eClinicalMedicine. 65. doi:10.1016/j.eclinm.2023.102304. PMC 10725075. PMID 38106564. Archived (PDF) from the original on 8 February 2024. Retrieved 8 February 2024.
Commissioner Oo (3 November 2018). "Jurisdictional Update: Drug-Eluting Cardiovascular Stents". FDA. Archived from the original on 8 December 2023. Retrieved 8 February 2024 – via www.fda.gov.
Piccolo R, Bonaa KH, Efthimiou O, Varenne O, Baldo A, Urban P, et al. (June 2019). "Drug-eluting or bare-metal stents for percutaneous coronary intervention: a systematic review and individual patient data meta-analysis of randomised clinical trials - The Lancet" (PDF). The Lancet. 393 (10190): 2503–2510. doi:10.1016/S0140-6736(19)30474-X. PMID 31056295. Archived (PDF) from the original on 8 February 2024. Retrieved 8 February 2024.{{cite journal}}: CS1 maint: overridden setting (link)
Aljihmani L, Alic L, Boudjemline Y, Hijazi ZM, Mansoor B, Serpedin E, et al. (2019). "Magnesium-Based Bioresorbable Stent Materials: Review of Reviews". Journal of Bio- and Tribo-Corrosion. 5 (1): 26. Bibcode:2019JBTC....5...26A. doi:10.1007/s40735-019-0216-x. S2CID 80811999. Archived from the original on 11 March 2024. Retrieved 11 March 2024.
Witte F, Eliezer A (2012). "Biodegradable Metals". Degradation of Implant Materials. Springer. pp. 93–109. doi:10.1007/978-1-4614-3942-4_5. ISBN 978-1-4614-3941-7. Archived from the original on 18 June 2018. Retrieved 11 March 2024.
Damian Garde for Fierce Medical Devices. 22 May 2013 Boston Scientific, Elixir make waves at EuroPCR 2013 Archived 16 January 2016 at the Wayback Machine
Husten L (6 April 2017). "Abbott Pulls Troubled Absorb Stent From European Market". CardioBrief. Archived from the original on 21 January 2021. Retrieved 2 November 2017.
Densford F (31 July 2017). "Boston Scientific to end Renuvia bioresorbable coronary stent program – MassDevice". +MassDevice. Archived from the original on 7 November 2017. Retrieved 2 November 2017.
Omar WA, Kumbhani DJ (2019). "The Current Literature on Bioabsorbable Stents: A Review" (PDF). Current Atherosclerosis Reports. 21 (12): 54. doi:10.1007/s11883-019-0816-4. PMID 31768641. S2CID 208278983. Archived from the original on 11 March 2024. Retrieved 11 March 2024.
Kirillova A, Yeazel TR, Asheghali D, Petersen SR, Dort S, Gall K, et al. (22 September 2021). "Fabrication of Biomedical Scaffolds Using Biodegradable Polymers". Chemical Reviews. 121 (18): 11238–11304. doi:10.1021/acs.chemrev.0c01200. PMID 33856196. Archived from the original on 13 March 2024. Retrieved 13 March 2024 – via CrossRef.
"Abbott Restarts Bioresorbable Stent Clinical Trials with New Esprit Below-the-knee Scaffold". 3 September 2020. Archived from the original on 1 October 2023. Retrieved 11 March 2024.
Malmonge SM, Cliquet C (2023). "Fully Bioresorbable Vascular Stents". Current Trends in Biomedical Engineering. Springer. pp. 255–268. doi:10.1007/978-3-031-38743-2_14. ISBN 978-3-031-38742-5. Archived from the original on 11 March 2024. Retrieved 11 March 2024.
Gogas BD, Farooq V, Onuma Y, Serruys PW (2012). "The ABSORB bioresorbable vascular scaffold: an evolution or revolution in interventional cardiology?" (PDF). Hellenic Journal of Cardiology. 53 (4): 301–309. PMID 22796817. Archived (PDF) from the original on 9 August 2017. Retrieved 13 January 2016.
"Drug-Eluting Stents Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028". Research and Markets Ltd. Archived from the original on 24 November 2023. Retrieved 24 November 2023.
"Drug-eluting Stent Market Size, share & Growth Research Report". www.bccresearch.com. Archived from the original on 24 November 2023. Retrieved 24 November 2023.
Bakalar N (27 February 2012). "No Extra Benefits Are Seen in Stents for Coronary Artery Disease". The New York Times. ISSN 0362-4331. Archived from the original on 24 November 2023. Retrieved 24 November 2023.
Kolata G (16 November 2019). "Surgery for Blocked Arteries Is Often Unwarranted, Researchers Find". The New York Times. ISSN 0362-4331. Archived from the original on 29 December 2022. Retrieved 24 November 2023.
Vani A (6 November 2013). "To Stent or Not to Stent?". Clinical Correlations. New York University (NYU) Department of Medicine. Archived from the original on 24 November 2023. Retrieved 24 November 2023.
"Expert Answers on E.M.D.R." Consults Blog. The New York Times. 16 March 2012. Archived from the original on 21 January 2024. Retrieved 24 November 2023.
"Patients Before Profits (1 Letter)". The New York Times. 5 March 2012. ISSN 0362-4331. Archived from the original on 24 November 2023. Retrieved 24 November 2023.
John DA (30 January 2013). "Unnecessary stent usage worries doctors across India". Times of India. Archived from the original on 26 June 2017. Retrieved 13 May 2015.
Hollmer M (30 January 2013). "In India, a call to halt financial incentives for stent use". Fierce Medical Devices. Archived from the original on 18 May 2015. Retrieved 13 May 2015.
Nagarajan R (15 September 2014). "Profits from medical devices used to bribe doctors?". The Times of India. Archived from the original on 16 December 2016. Retrieved 13 May 2015.
Park A (3 February 2023). "Boston Scientific fined $42M in stent patent lawsuit". Fierce Biotech. Archived from the original on 24 November 2023. Retrieved 24 November 2023.
"Boston Scientific hit with $42M verdict in drug-eluting stents IP case". 2 February 2023. Archived from the original on 8 February 2024. Retrieved 8 February 2024.
"Annual Review of Medical Device Patent Litigation | Publications | Insights". Faegre Drinker Biddle & Reath LLP. Archived from the original on 24 November 2023. Retrieved 24 November 2023.
"Heart Stent Problems - Drug Eluting Stent Lawsuits". Saiontz & Kirk, P.A. Archived from the original on 24 November 2023. Retrieved 24 November 2023.
"Heart Stent Class Action Lawsuit". The Schmidt Firm, PLLC. Archived from the original on 24 November 2023. Retrieved 24 November 2023.

worldcat.org

search.worldcat.org

George S, Butler R, Nolan J, Mamas MA (30 June 2016). "Percutaneous Coronary Intervention and Bleeding Complications". EMJ Interventional Cardiology. 4 (1): 100–109. doi:10.33590/emjintcardiol/10314557. ISSN 2053-423X. S2CID 256147538. Archived from the original on 19 November 2023. Retrieved 19 November 2023.
Habib A, Mori H, Yahagi K, Finn AV (3 February 2017). "Contemporary Drug-Eluting Stents and Vascular Response". EMJ Interventional Cardiology. 2 (1): 60–68. doi:10.33590/emj/10314324. ISSN 2053-423X. S2CID 13713278. Archived from the original on 5 November 2023. Retrieved 5 November 2023.
Kirtane AJ, Mauri L, Stoler R, Feldman R, Neumann FJ, Boutis L, et al. (22 September 2018). "TCT-841 Baseline characteristics and 3-month outcomes of the EVOLVE Short DAPT Trial: A prospective investigation of abbreviated antiplatelet therapy in high bleeding risk patients treated with a thin-strut bioabsorbable polymer-coated, everolimus-eluting coronary stent". Journal of the American College of Cardiology. 72 (13 Supplement): B335 – B336. doi:10.1016/j.jacc.2018.08.2086. ISSN 0735-1097.
Bakalar N (27 February 2012). "No Extra Benefits Are Seen in Stents for Coronary Artery Disease". The New York Times. ISSN 0362-4331. Archived from the original on 24 November 2023. Retrieved 24 November 2023.
Kolata G (16 November 2019). "Surgery for Blocked Arteries Is Often Unwarranted, Researchers Find". The New York Times. ISSN 0362-4331. Archived from the original on 29 December 2022. Retrieved 24 November 2023.
"Patients Before Profits (1 Letter)". The New York Times. 5 March 2012. ISSN 0362-4331. Archived from the original on 24 November 2023. Retrieved 24 November 2023.

yalemedicine.org

"Percutaneous Coronary Intervention (PCI)". Yale Medicine. Archived from the original on 22 October 2023. Retrieved 21 October 2023.
"Percutaneous Coronary Intervention (PCI)". Yale Medicine. Archived from the original on 22 October 2023. Retrieved 21 November 2023.

youhavealawyer.com

"Heart Stent Problems - Drug Eluting Stent Lawsuits". Saiontz & Kirk, P.A. Archived from the original on 24 November 2023. Retrieved 24 November 2023.